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The effect of disturbed flow profiles on the endothelium have been studied 
extensively in systemic vasculature, but less is known about the response of the blood-
brain barrier (BBB) to these flow regimes. Here we investigate the effect of steady and 
pulsatile disturbed flow on the integrity of the BBB using a three-dimensional, perfusable 
bifurcation model consisting of a co-culture of endothelial cells with mural and glial cells. 
Experimental flow patterns predicted by computational fluid dynamics mimic in vivo flow 
regimes, specifically the presence of a recirculation zone immediately downstream of the 
bifurcation reveal periodic changes in the instantaneous shear stress along the channel wall. 
Dextran permeability assays and immunostaining with markers for tight junctions show 
that barrier disruption is significantly greater in areas of disturbed flow compared to fully 
developed regions downstream of the bifurcation. RNA sequencing found differences in 
gene expression between the disturbed and fully developed regions, and lumican which has 
been implicated in ECM organization and collagen fibrillogenisis was shown to be 
significantly upregulated in the fully developed region. Furthermore, the downregulation 
of the protein is associated with barrier breakdown. Overall, disturbed flow-induced 
disruption of the blood-brain barrier suggests that flow-mediated mechanisms may 
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           A key determinant in brain pathology and homeostasis is the impact of blood flow 
regimes on the integrity of the blood-brain barrier (BBB). Numerous studies have 
validated that the integrity of the BBB is sensitive to the wall shear stress applied by 
blood flow. While physiological wall shear stress has been shown to maintain barrier 
integrity and brain homeostasis, low levels of fluid shear stress have been associated with 
higher BBB permeability and disruption of its integrity 1. The breakdown of the BBB has 
been associated with several neurological disorders including but not limited to stroke, 
Alzheimer’s disease, and traumatic brain injury 2-4. Furthermore, the integrity of BBB is 
important at all levels of the vascular tree within the CNS5,  including the large arteries in 
the subarachnoid space. At these locations, vessels are characterized by temporally and 
spatially varying wall shear stress6  due to the pulsatility of blood flow7 and the tortuosity 
of the vascular bed at those locations 8, 9. In addition, there is a potential of disturbed flow 
regions at these locations due to flow separation from the wall at vascular bifurcations. 
These variations have been associated with abnormal flow patterns, non-physiological 
wall shear stress profiles and therefore breakdown of the BBB.  Several studies have 
associated the BBB dysfunction caused by altered blood flow regimes at these locations 
with aneurysm initiation, suggesting that altered shear stress may disrupt the BBB at 
these locations due to the presence of recirculation eddies caused by disturbed flow. 
            There is growing evidence suggesting that aneurysm formation is widely 
associated with tight junction disruption as well as degradation of the basement 
membrane proteins10, 11. Furthermore, there are several signaling mechanisms that could 
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mediate the response to disturbed flow, including mechanosensitive small GTPases, that 
upon activation, have been implicated in the regulation of the BBB through the RhoA-
ROCK signaling pathway 12, 13. Moreover, RhoA activation is associated with tight 
junction maintenance as well as interactions with extracellular matix (ECM) components, 
providing further evidence that the small GTPase may mediate endothelial 
mechanotransduction. Therefore, interrogating the impact of time-dependent flow 
patterns on the endothelial cells response inside complex vascular geometries mimicking 
cerebral vasculatures can elucidate the molecular mechanisms underlying the 
mechanotransduction of disturbed flow on the BBB integrity and function.  
             Previous studies have demonstrated that the phenotype of endothelial cells in 
systemic vasculature is markedly different than in the brain 14-16.  However, the effect of 
altered shear stress on the integrity of the BBB has not been studied as thoroughly17-
19.While endothelial cells in the systemic vasculature can withstand hemodynamic stress 
and maintain vascular integrity when exposed to laminar flow 20-22, disturbed flows in the 
separation zone 9, 23, 24 and reattachment point 25-27 contribute to vasculature dysfunction 
and altered gene expression 28. In addition, disturbed flow has been shown to destabilize 
cell-cell and cell-ECM contacts adjacent to bifurcations21, 22, 27, 29. Such destabilization in 
the brain would lead to barrier breakdown. Yet, the impact of time-dependent disturbed 
fluid flow on the integrity of the BBB in a geometry that mimics cerebral bifurcation has 
yet to be investigated. Therefore, there is a need for a 3-dimensional (3D) BBB model to 
interrogate the response of endothelial cells to the different flow regimes. Previous 
studies have used in vitro models to recreate the fluid mechanics of the endothelial 
microenvironment25, 26. In contrast to animal models, in vitro models provide a higher 
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level of control over fluid flow regimes exposed to the endothelium. These systems have 
applied both steady and pulsatile flow to cerebral endothelial cells in both two-
dimensional (2D)2, 27, 28  and three-dimensional (3D) geometries30. In contrast, 3D 
bifurcation models that create disturbed flow regimes in geometries that are more similar 
to in vivo vasculature, are yet to be investigated.  
             Therefore, the approach described here involves a cerebral bifurcation model 
constructed inside a microfluidic device to establish a mechanistic link between disturbed 
flow and aneurysm formation in a platform that mimics the brain microenvironment. The 
model includes a 3D co-culture of three different cell types. Here, both glial and mural 
cells are incorporated into a co-culture model with the endothelium to approximate the 
vessel bore that experiences disturbed flow in vivo, since larger arteries exhibit a 
prominent mural layer that supports the augmented pressure differences incurred by 
higher flow rates. An annulus of smooth muscle cells surrounds the endothelial lumen, 
and the annulus itself is surrounded by an astrocyte-seeded hydrogel, to approximate the 
arrangement of these cells in vivo 31. Furthermore, the vessels are patterned within a 
microfluidic device that is capable of applying different fluid flow levels with a 
sufficiently high Reynolds number to separate from the wall of the endothelial lumen, 
yielding an experimental setup that can directly interrogate the response of the BBB to 
altered shear stress profiles. Here, the desired physiological pulsatile waveform was 
successfully generated using a low-cost linear actuator and components fabricated from a 
common fused deposition modeling (FDM) 3D-printer. The system divides the task of 
flow waveform generation between two components: the peristaltic pump which 
generates steady flow and a linear actuator generating oscillations to recreate the systolic 
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and diastolic pressures. The model described here provides a platform to study the effect 
of time dependent altered shear stress on the integrity of the BBB in a 3D in vitro setting 
that mimics several aspects of the in vivo microenvironment of the brain vasculature.  
               Throughout the studies, the flow characterization was conducted using both 
experimental and computational fluid dynamic models. The cellular response was 
quantified using immunofluorescence, immunoblotting, Permeability assays, 
Bromodeoxyuridine / 5-bromo-2'-deoxyuridine (Brdu) assays and rheology. In addition, 
RNA sequencing along with bioinformatics was used to determine differential gene 
expression in the endothelium exposed to steady flow. Finally, gene knockdown was 
utilized to modulate the expression of the proteoglycan lumican to probe its impact on the 
integrity of the BBB and the activation of the small-GTPases. This dissertation is 
organized into five chapters. Chapter 1 is the introduction. Chapter 2 represents the 
background information on the BBB and the different flow regimes as well as the current 
models used to study the impact of flow on the endothelium in the brain. It finally 
introduces the specific aims for the dissertation. Chapter 3 details the experimental 
approach utilized, the computational fluid dynamics models and the in vitro experimental 
setup. Chapter 4 summarizes the results investigating the impact of both steady and 
pulsatile flow on the BBB integrity. It also details the RNA sequencing results to 
determine the differentially expressed genes in the endothelium exposed to steady flow. 
Finally, it underlines the mechanistic link between the BBB disruption and aneurysm 
formation using gene knockdown. Finally, Chapter 5 summarizes all the experimental 







2.1. The Blood-Brain Barrier (BBB) 
 
              2.1.1. Introduction to the BBB. The blood-brain barrier is a complex biological 
barrier that separates select blood components from the parenchyma of the brain, which 
along with the spinal cord make up the central nervous system (CNS)32-34. It plays a key 
role in maintaining brain homeostasis35-37 as well as facilitating the transport of nutrients 
and other solutes through the CNS37. The BBB is present in all scales of blood vessels in 
the brain38 and is formed by endothelial cells (ECs) lining the brain vasculature, pericytes 
and astrocyte end feet35, and a basal membrane that separates ECs from pericytes, and 
astrocytes39, 40. The development and maintenance of the BBB are governed by cellular 
and non-cellular elements that interact with the ECs. While, astrocytes, pericytes, and the 
extracellular matrix (ECM) components provide both structural and functional support to 
the BBB, the endothelial cells exhibit a unique phenotype, making the brain capillaries 50 
to 100 times tighter than peripheral microvessels as a result of tightly sealed monolayer 
of endothelial cells with  tight junctions (TJ) and adherens junctions (AJ)41. In addition, 
the basal membrane and astrocyte end-feet contribute to BBB function and integrity by 
regulating the expression of specific TJ proteins and other BBB transporters.  
            Brain tight junctions have different biological functions and are composed of 
integral membrane proteins including claudins and occludins42 43,  which are involved in 
intercellular contacts and interactions with cytoplasmic scaffolding proteins such as 
zonula occludens-1(ZO-1) proteins (Fig.1) , actin cytoskeleton and associated proteins, 
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such as protein kinases, small GTPases44 and heterotrimeric G-proteins45. They serve to 
limit the BBB permeability and increase the barrier’s electrical resistance by limiting 
transport through cell-cell junctions. 
 
 




2.1.2. The impact of shear stress on BBB integrity.  Several in vitro studies 
have shown that formation and maintenance of the BBB in microvascular models 
requires exposure to fluid shear stress1, 15. In fact, the wall shear stress applied by the 
blood flow has been shown to have a detrimental effect on endothelial cell function, 
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morphology, gene expression and barrier integrity through the regulation of several tight 
junction proteins. Several studies have shown that exposure to capillary-like shear stress 
levels (6.2 dynes/cm2) increases the RNA levels of a variety of tight and adherens 
junction components such as zonula occludens-1 (ZO-1), Claudin 3 and 5, cadherins, 
catenin α2 and β1, and actin α21, 46, 47  in addition to reducing barrier permeability and 
promoting actin cytoskeleton reorganization 42, 48, 49. However, low levels of fluid shear 
stress have been associated with lower expression of tight junction proteins, breakdown 
of the barrier and higher permeability. 
2.1.3. The impact of the vasculature topology on flow and disease. The BBB 
exists at all levels of the vascular tree within the CNS (Fig. 2)5 including the arteries and 
arterioles, the dense capillary bed, the venules and veins. Therefore, the integrity of the 
barrier is crucial not only in the microvasculature within the brain parenchyma, but also 
in the larger pial and cerebral arteries in the subarachnoid space [89]. In these vessels, 
the BBB includes an additional layer of smooth muscle cells and is exposed to a time 
varying flow and higher Reynolds numbers. There is a potential for disturbed flow, 
especially at arterial bifurcations due to the tendency to separate from the wall at these 
locations 20, 50. In addition, the vascular topologies exacerbate the blood flow patterns at 
these locations6 and expose the endothelium to a time-dependent shear stress field 
varying is magnitude during the cardiac cycle, with periodic appearance of flow 
separation zones, yielding oscillating wall shear stress profiles6, 9.  Therefore, changes in 
the blood flow profiles could trigger BBB and TJ disruption, and lead to increased 
extravasation of immune cells across the BBB, leading to decreased CNS protection and 





Figure 2.The vascular neural network 51. 
 
 
               Changes in blood flow have been associated with BBB disruption in several 
neuropathological conditions including dementia and Alzheimer’s, epilepsy and ischemic 
stroke 2-4. In addition, evidence that the incidences of aneurysms and endothelial 
dysfunction are higher at bifurcations in cerebral arteries 52, 53 suggests that altered shear 
stress may disrupt the BBB at these locations.  
             Several studies investigating the impact of wall shear stress on the vasculature in 
the brain demonstrated that flow dynamics play an important role in the initiation, growth, 
and rupture of cerebral artery aneurysms54-56. In fact, the wall shear stress applied on the 
bifurcation has been shown to play a huge role in aneurysm initiation and rupture. Studies 
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demonstrated that larger bifurcation angles lead to abnormally enhanced hemodynamic 
stresses and enlarged zones of direct flow impingement and recirculation eddies54. In 
addition, a study conducted by Hassan et.al 55 investigating the response of human 
umbilical vein endothelial cells to hemodynamic stresses in  an actual  patient-specific 
cerebral aneurysm model showed that the aneurysmal dome experiences relatively low 
WSS compared with the impingement zone at the distal aneurysm neck and downstream 
parent vessel. Furthermore, the study showed that high levels of shear stress profiles 
impacted endothelial cells morphology and orientation. These results indicate that 
abnormal flow profiles lead to the dysfunction of the endothelial cells which in return is 
associated with cerebral aneurysms. 
2.1.4. Models of the BBB. To better understand the physiology of brain 
vasculature, there is a need to develop experimental models that mimic the properties and 
function of the BBB or directly perform experiments in living organisms. Ideal BBB models 
mimic the cell types and distribution within the in vivo microenvironment and have high 
selective permeability to different substances 35. Several BBB models have been developed 
in the past including in vivo, static, and perfusable 2D and 3D models.  
2.1.4.1.  In vivo models. In vivo BBB models were investigated in the past by 
performing experiments in animals. The main advantage of these models is that the 
experiment occurs under natural conditions and can generate large amounts of reliable 
data 57. In addition, they closely mimic the complexity of human physiology and the brain 
microenvironment. In these models, the function of the BBB is studied using several 
methods consisting of, intravenous injection and brain perfusion 58. However, the main 
disadvantage of the in vivo studies is the complexity of the in vivo microenvironment that 
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prohibits robust control of the fluid dynamics environment. In addition, animal-to-animal 
variability represents an additional limitation that makes in vitro experiments an 
alternative for studying the function and response of the BBB to flow.  
2.1.4.2.  Current Experimental BBB models.  In vitro models for 
cerebrovascular studies of the BBB started to emerge in the early 1990s as potential new 
research tools complementary to in vivo and human studies. These models are a major 
focus in research due to their ability to replicate the vascular properties and the brain 
microcapillaries microenvironment. They provide highly controllable environments in 
vitro to manipulate cells and tune specific physiological and experimental stimuli 
difficult to reproduce in vivo.  These models include static culture systems, flow-based 
systems, two-dimensional and three-dimensional extracellular matrix-based models. The 
primary caveat of these models is the inability to fully recreate the complexity of the in 
vivo microenvironment 
      2.1.4.2.1. Static models. Previous studies have relied on static BBB models 
that feature either endothelial cells or multiple cell types cultured on semi-permeable 
microporous inserts 59. The mono-culture models represent a simplistic reconstruction of 
the BBB and therefore do not capture the complex architecture of the BBB including the 
interaction with other cell types, which is crucial for the properties and functions of the 
BBB. In co-culture experimental models, brain microvasculature endothelial cells 
(BMECs) and other BBB cell types such as astrocytes and pericytes have been cultured 
on different sides of a membrane 60. While, the addition of astrocytes has been shown to 
facilitate the formation of tight junctions and the overall expression of BBB features, 
these models lack a number of necessary features for the development of BBB properties 
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in vitro. They exhibit high permeability due to the absence of physiological stimuli which 
significantly limits the ability of the vascular endothelium to develop and maintain the 
BBB properties and functions observed in vivo 61, 62 . Lacking the continuous exposure to 
wall shear stress, affects the integrity of the barrier and causes major differences in cell 
morphology and barrier permeability when compared with in vivo models 63.  
 2.1.4.2.2.  Perfusable BBB models.  Recent advances in vascular patterning have 
enabled the development of in vitro models that can closely mimic in vivo geometries and 
microenvironments 64. These advances can build upon previous BBB models that have 
relied on two-dimensional geometries 65, 66 or used three-dimensional models that mimic 
small diameter vessels by co-culturing endothelial cells with astrocytes or pericytes 67, 68. 
Several models were created using microfluidic chips and a variety of techniques, such as 
the gelation of ECM around a removable template rod 69, 70, soft lithography71, and 3D 
printing72 . However, microfluidic chip models exhibit unique advantages in the BBB 
research due to their ability to mimic the in vivo microenvironment. These devices can be 
tuned to meet specific experimental requirements due to their ability to mimic the size of 
microvascular structures in vivo and allow for fluid control. Therefore, these models can 
be used to interrogate cell morphology, and permeability of the BBB in response to fluid 
flow.  
            While the current 3D BBB models showed their utility to study and characterize 
the role of the BBB in the pathogenesis of major neuroinflammatory diseases, they lack a 
physiologically relevant diameter to model large arteries in the subarachnoid space that is 
necessary to study aneurysm formation. They are also limited due to the inability to support 
high Reynolds numbers required to induce flow separation (Re > 100)  and sustain high 
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fluid flow levels for a continuous period of time (e.g. 24 h). Moreover, current in vitro 
models of cerebral vasculature are inadequate for studying the effects of disturbed fluid 
flow due to a lack of three-dimensionality, dependence on synthetic meshes to support the 
endothelium and the lack of smooth muscle cells in the co-culture model.     
2.1.5.  Endothelial cells used for BBB models. Several endothelial cells types 
have been utilized to replicate the BBB characteristics (Table.1). Initially, in vitro models 
relied on primary brain microvasculature endothelial cells (BMECs), however these cells 
are post-mitotic and difficult to isolate. Therefore, several human and animal cell lines have 
been developed to model the BBB to overcome the limitations of using BMECs. Among 
these cells, cultured human brain (human brain microvascular endothelial cells, HBMECs) 
and non-brain HUVECs vascular cells became available in the early 1980s and exhibit 
excellent characteristics for the study of the developmental and pathophysiological 
processes of the BBB. Unfortunately, the high level of difficulty associated with isolating 
these cells from the brain tissue as well as their rapid senescence, made their use costly and 
time consuming. Therefore, immortalized cell lines from diverse origins have been 
developed, in the BBB research and include hCMEC/D3, a human adult cerebral 
microvascular endothelial cell line73 .These cell lines have many advantages over primary 
cultures and other cell types, which include being easy to grow in addition to retaining their 
differentiating properties after several passages with a reduced time to reach confluency. 
Therefore, they decrease the workload, cost, and labor. But some studies reported that 





Table 1  
Summary of previously used endothelial cells to model the BBB 
Cells  Advantages  Disadvantages  
Primary75 76-78 -Close initial resemblance 
to in vivo conditions 
-Post-mitotic 
 -Difficult to obtain 
Immortalized 17, 79, 80 -Stable over numerous 
passages 
-Could lose their phenotype 
after numerous passages 
-Genetically modified  
IPSC- derived 81-83 - Renewable source 
 
 -Patient specific 84-88 
-Require differentiation and 
thorough characterization 
-Current protocols do not 
result in a true 
representation of the BBB 
phenotype 89 
HUVECS  -Can be isolated in large 
amounts  
-Easy to obtain 
-Not a true representation of 
the BBB phenotype 
Fetal derived cells 90-93 -More representative 
model 
-TJP expression is 
characteristic of mature 
barrier properties 
-Generate controversy from 




2.2. Problem Statement And Specific Aims  
 
The following dissertation develops and characterizes an in vitro vascular model of 
a cerebral artery that controls both the mechanical and biochemical environment of a co-
culture of endothelial cells, smooth muscle cells, and astrocytes. The model will interrogate 
the overall hypothesis that disturbed flow promotes aneurysm formation by modifying 
endothelial gene expression profiles related to extracellular matrix remodeling and the 
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formation of tight junctions. The proposed study is organized into the following specific 
aims: 
Aim 1: Analyze the effects of disturbed flow on the integrity of the blood-brain barrier 
adjacent to arterial bifurcations. Aim 1 assesses the effects of disturbed fluid flow from 
both steady and pulsatile flow on blood-brain barrier (BBB) integrity using 
immunofluorescence and dextran permeability assays. These studies evaluate the 
hypothesis that altered shear stress exerted by disturbed flow disrupts endothelial tight 
junctions.  
Aim 2: Determine differentially expressed genes in the endothelium exposed to altered 
flow regimes using RNA sequencing of vessels exposed to both steady and pulsatile flow. 
After interrogating the effect of flow on the BBB, Aim 2 compares gene expression profiles 
in regions of the vessel exposed to different flow regimes (fully developed, disturbed, 
impingement, and a static control) using next generation sequencing methods (RNA-seq). 
The proposed approach tests the hypothesis that disturbed flow alters the expression of 
genes in endothelial cells associated with extracellular matrix remodeling and organization 
and tight junction formation. 
Aim 3: Interrogate the molecular mechanisms underlying the endothelial response to 
disturbed flow. Aim 3 focuses on measuring the activation of small GTPases associated 
with mechanotransduction and barrier regulation, including RhoA and Rac1, to provide 
insight into signaling mechanisms associated with disturbed flow. These studies will also 
use the findings of the previous aim regarding differentially expressed genes to investigate 
mechanistic effects. Overall, this aim addresses the hypothesis that the expression of 
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extracellular matrix components altered during exposure to disturbed flow mediates 





















Methods and Materials 
 
3.1. Experimental Methods  
3.1.1. Vessel fabrication. 
 
         3.1.1.1. Microfabrication of microfluidic device. Polydimethylsiloxane (PDMS) 
microfluidic devices were manufactured by soft lithography using a previously described 
protocol 15. Briefly, SU-8 2025 photoresist (MicroChem) was deposited on a silicon wafer 
and exposed to a UV source through a mask with the desired geometry. The inlet was 
positioned at an angle of 45 degrees to induce separated flow within the range of Reynolds 
numbers appropriate for modeling arterial blood flow (Re = 50-200). PDMS was used to 
cast negative and positive molds of the design and to pattern devices on 22mm x 40mm 
glass cover slips. The hydrogel reservoir had dimensions of 6.5 x 6.5-mm and a height of 
approximately 2-mm. Prior to adding a hydrogel to the device, the reservoir was filled with 
5M sulfuric acid, washed with distilled water, and incubated in dilute type I collagen (20 
g/mL) to facilitate hydrogel attachment to PDMS 94. The devices were then sterilized 
using short wavelength UV prior to channel seeding.  
               3.1.1.2.   Cell culture. Normal human astrocytes (NHA) (Lonza) were thawed at 
passage 5 and cultured for 10 days in astrocyte growth medium (AGM) (Lonza) prior to 
seeding in the microfluidic device. Human Coronary Arterial Smooth Muscle Cells 
(HCASMC) (Sigma) were also thawed at passage 5 and cultured in smooth muscle growth 
medium (Sigma) until confluency, then passaged and cultured in 6 well plates using smooth 
muscle cell differentiation medium (Sigma) for 10 days prior to vessel fabrication. 
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Additionally, human cerebral microvascular endothelial cells (HCMEC/d3) received at 
passage 19 (gifted from Dr. Robert Nagele’s laboratory) were cultured and expanded on 
tissue culture plates coated with 1% gelatin in EGM-2 modified with CD lipid concentrate 
and HEPES buffer according to a previously described protocol 17. 
               3.1.1.3.   In vitro vessel fabrication.  Normal human astrocytes (NHA) were 
seeded at a density of 1 million cells per mL in a 10 mg/mL collagen, 1.33 mg/mL 
hyaluronan (HA) and 1 mg/mL Matrigel hydrogel formulation used in a previous study95. 
After injecting the gel directly into the reservoir, an 18-g needle coated with 0.1% Bovine 
Serum Album (BSA) (Sigma) was inserted into the device through the 18-g needle guide. 
After waiting 20 minutes to allow for gel polymerization, the needle was pulled to create a 
cylindrical void, and AGM was added through Port 1 to maintain cell viability. HCASMC 
were then seeded into a 10 mg/mL collagen and 1 mg/mL Matrigel composite hydrogel at 
a density of 1 million cells per mL. The AGM was aspirated prior to injection of the 
hydrogel through Port 3, and a 20-g needle coated in 0.1% BSA in PBS was inserted inside 
the void lumen using the 20-g needle guide. The 20-g needle was then removed, leaving a 
final cylindrical void and surrounding annulus. HCMEC/d3 were resuspended in EGM-2 
at a density of 5 million per mL. 15 μL of the HCMEC/d3-containing solution was injected 
into the channel through Port 1 and incubated for 10 minutes, yielding a seeding density of 
approximately 150,000 cells per cm2. This process was repeated for an additional 10 
minutes after inverting the device to assure uniform lumen coverage throughout the 
channel. Silicone grease was used to close the 18-g needle guide and Port 2. Port 2 was 
blocked to increase the length of the recirculation zone along the cell-seeded channel by 
effectively closing the non-cell seeded branch of the bifurcation. Devices were left in static 
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conditions for 2 days submerged in EGM-2 to ensure cell spreading and viability prior to 
exposure to flow or static conditions.  A total of 29 vessels were fabricated using this 
method (three for flow validation, six for proliferation assays and viability assays, five for 
immunohistochemistry, and nine for permeability testing).  
                 3.1.1.4.  LifeAct transfection. P3 HCASMC cultured in SMC growth medium 
(Cell Applications) were transfected with RFP LifeAct lentivirus (Ibidi) at a MOI of 2.5. 
Following 48 hours of incubation with the virus RFP positive cells were selected by adding 
5 mg/mL Polybrene until only transfected cells remained attached to the culture plate. 
Additionally, HCMEC/D3 cells were incubated with lentiviral particles containing copGFP 
using a MOI of 1 overnight. The cells were then washed and incubated in EGM-2 and 
exposed to 10 mg/mL puromycin until ~90% of adhered cells expressed GFP. Transfected 
cells were then cultured and used for experiments as needed. 
            3.1.2. Barrier integrity assessment.  
 
            3.1.2.1.  Immunocytochemistry. Four vessels were fabricated using the previously 
described method. After two days in static culture following cell-seeding, the vessels were 
either left in static conditions or perfused for 24 hours. Upon completion of the experiment, 
vessels were fixed in 4% paraformaldehyde (Alfa Aesar) for 30 min at room temperature. 
Following fixation, the top layer of the microfluidic device was separated using a razor 
blade, and the hydrogel was then removed from the device. Immunolabeling was then 
performed after blocking in 3% BSA for 30 minutes at room temperature and incubating 
overnight at 4 C in a primary antibody for either zonula occludin-1 (ZO1) (1:250, Cell 
Signaling Technology, Product 8193), claudin-5 (1:250, Invitrogen, Product 35-2500), 
occludin (1:250 Invitrogen, Product 71-1500), glial fibrillary acidic protein (GFAP) 
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(1:100, Santa Cruz, Product sc-166481), or alpha smooth muscle cell actin (1:100, 
ThermoFisher, Product 41-9760-80). Gels were then washed three times with PBS for 5 
minutes and incubated in the appropriate secondary antibody (1:500, Santa Cruz, assorted), 
1:500 Hoechst (Sigma), and FITC-phalloidin (Life Tech, F432) for 1h at 37 C. Confocal 
stacks were acquired using a Nikon A-1 confocal scanning microscope.  
                3.1.2.2. Permeability testing. Nine vessels were used to quantify the 
permeability of the vessels following perfusion or static culture. At the completion of the 
24-hr experiment, the microfluidic devices were placed on the stage of an inverted 
epifluorescent (Nikon Ti-E) and perfused with 4 kDa FITC-dextran (Sigma) at a flow rate 
of 10 μL/min using a linear syringe pump over the span of 10 minutes. This flow rate was 
chosen to avoid any flow separation and assure fully developed flow throughout the 
channel and to maintain consistency with previously described permeability assays 15. 
Images were taken at 30-s intervals and then imported into ImageJ for analysis. The 
permeability coefficient was determined using the following equation96: 









 is the change in florescent intensity of the region of interest outside the lumen, r 
is the lumen radius (472 m) and I0 is the maximum intensity in the lumen during the test. 
Permeability was measured at three separate locations corresponding to fully developed 
flow, near side wall disturbed flow (separated flow), and far side disturbed flow 




             3.1.2.3. Cell proliferation assays. Three additional vessels were constructed for 
proliferation assays, which were based in part on a previous study 50. Briefly, vessels were 
perfused for 12 hours with EGM-2 using the peristaltic pump and then exposed to 10 M 
Bromodeoxyuridine (BrdU) (Alfa Aesar) for the remaining 12 hours. Devices were then 
briefly washed in PBS and fixed in 4% v/v paraformaldehyde for 30-min at room 
temperature, quickly washed in PBS, and then permeabilized with 0.2% Triton x100 in 
PBS for 20 min at room temperature. DNA hydrolysis was performed by removing the 
hydrogels from the devices and soaking them in a solution consisting of 4 units per mL 
Turbo DNAse (Thermo fisher) and 0.1 mL DNAse Buffer (Thermo fisher) in PBS for 1 
hour at 37C. Gels were washed with PBS then incubated overnight at 4 C with 0.8 g/mL 
PE-labeled anti-BrdU (Biolegend) and 1% BSA in PBS. Gels were then counter stained 
with 1 g per mL Hoechst for 45 minutes at 37C. In ImageJ, thresholding was used to 
isolate nuclei prior to using watershedding to isolate individual cells. The ImageJ cell 
particle counter was used to count the number of nuclei present at three regions of interest 
in both the disturbed (at the stagnation point) and fully developed regions. In the disturbed 
region, n = 316-432 Hoechst-positive nuclei were counted. In the fully developed region, 
n = 261-340 nuclei.  
              3.1.2.4. Viability assays. Additional vessels were fabricated for viability 
experiments. Viability was assessed using a Live/Dead kit (Biotium) consisting of calcein 
AM (2 M) and ethidium homodimer (4 M). Vessels were again incubated in static 
conditions for two days prior to application of flow for 24 hours (controls remained in static 
conditions for those 24 hours), and then removed from the flow setup, rinsed with PBS, 
and incubated for 45 minutes in the staining medium prior to imaging. ImageJ was used to 
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calculate the number of live and dead cells in three different regions for each vessel (three 
vessels were used for both flow and static conditions). 
         3.1.2.5. Alignment quantification. Endothelial cell alignment was quantified by 
transforming the spatial information from the ZO-1 signal into the frequency domain using 
a fast Fourier transform (FFT) calculated by ImageJ as described in a previous publication 
97. A Gaussian curve was fit to the frequency data, and the half-width of the curve was 
calculated for cells exposed to fully developed and disturbed flow. This process was 
repeated for three separate 100 x 100-μm sections from a single immunofluorescence 
image.  
           3.1.2.6. Statistical analysis. Pairwise t-tests were used to compare measurements 
of permeability coefficients and positive BrdU staining. Each comparison was made for 
sample numbers greater than or equal to 3, and p < 0.05 was considered significant. A test 
for normality was performed using the Shapiro-Wilk test, and p<0.05 was considered 
statistically different from a normal distribution. 
 3.1.3. Perfusion.  
 
    3.1.3.1. Computational fluid dynamics. A computational fluid dynamics (CFD) 
model was used to predict the flow fields present in the 3D vessels patterned within the 
microfluidic devices. Prior to the application of flow, brightfield images were acquired of 
the vessels and used to generate a SolidWorks model that was imported into a commercial 
finite volume code (Star-CCM+) and discretized by a polyhedral mesh. The maximum flow 
rate of the peristaltic pump used in our experiments was 4.5 mL/min, so the maximum 
Reynolds number within the vessels was calculated to be 191. Thus, the flow was laminar 
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in its entirety and there was a sufficient entrance length between Port 1 and the bifurcation 
to allow for the flow to become fully developed prior to reaching the bifurcation. 
Furthermore, the Reynolds number necessitated inertial terms in the constitutive flow 
equation: 
                                ρ (𝑉⃗⃗⃗⃗ ·∇ ?⃗? ) = -∇p + μ 𝛻2 ?⃗?                                                       
 
where ρ is the fluid density (kg/𝑚3), ?⃗?  is the fluid velocity vector (m/s), p is the fluid 
pressure (Pa), and μ is the dynamic viscosity (Pa-s). Additional prism layers were defined 
in the mesh along the wall boundary to ensure that the near wall effects were adequately 
resolved. The input flow rate was applied as a velocity boundary condition at Port 1. The 
gauge pressure at the 20-g needle guide was set to zero, since this provided the outlet for 
the flow. No-slip boundary conditions were applied at the walls and at Ports 2 and 3 and 
the 20-g needle guide (locations blocked with silicone grease) to set the velocity to zero 
at these boundaries. The simulation was run until the solution converged using a steady-
state solver. 
3.1.3.2.  Micro-particle image velocimetry flow validation. Micro-particle 
image velocimetry (μPIV) was used to validate the CFD model for three independent 
channels and to characterize the flow regimes present in these channels. Vessels were 
perfused with steady state flow by a syringe pump (Kent Scientific) at the flow rates 
determined by the computational model for their individual geometries. These 
magnitudes ranged from 4 mL/min to 4.5 mL/min. Polyethylene microspheres labeled 
with Nile Red (Peak excitation: 640nm; mean diameter 1.95 μm; Spherotech Inc.) were 
suspended 1:500 in PBS containing 0.1% Triton X-100 to prevent bead aggregation and 
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illuminated and visualized with a dual pulse Nd:YAG laser (125mJ/pulse, 15 Hz, 532 
nm; Dantec Dynamics). The pulse width of the lasers was set to 100 ns and the 
illumination set at a frequency of 0.1 Hz for two seconds (20 individual velocity 
measurements). Particles were visualized with 10x objective on a Nikon Ti-E inverted 
microscope, where the focal plane was set to the channel’s midpoint. Images were 
captured using a double-frame CCD camera (FlowSense EO, Dantec Dynamics). 
Velocity contours were calculated in Dynamic Studio (Dantec Dynamics) using an 
adaptive PIV algorithm. Velocity contour plots were generated in MATLAB by taking 
the mean of the 20 velocity measurements. In order to calculate the shear stress at points 
along the vessel wall, a second order polynomial was fit to the velocity in the boundary 
layer, and the slope of that function at the wall was calculated.  
 
3.1.3.3. Design of the pulsatile flow system. The peristaltic pump system 
was controlled using an Arduino-based system 98 . A peristaltic motor (Welco) was 
controlled by an Arduino Uno (Arduino) and a motor board (Ada Fruit). The flow rate 
magnitude was controlled by using the Arduino to regulate DC voltage powering the motor. 
A Sensiron flow sensor was used in-line of the perfusion system to monitor the steady flow 
rate and pulsations. To mimic the arterial pulsation, the pulsatile flow system was designed 
by superposition of oscillations with the constant mean flow driven by the peristaltic pump. 
The system included a damper placed in series with the channel, to eliminate the 
oscillations coming from the peristaltic pump, and a Limnot® linear motor, which was 
programmed to generate the flow waveform via displacing a 5 mL syringe connected to the 
actuator system using the LinMot software (open source)99. 120mm 12v fans (Corsair) 
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were mounted to the linear motor to regulate the temperature and prevent the system from 
overheating.  
3.1.3.4. 3D printing and system assembly. The linear actuator along with 
the 5mL syringe were placed on a 3D printed assembly system to facilitate the movement 
of the actuator and the syringe while fixing the other components in place. The 3D printed 
parts were designed using Solidworks then, imported into ultimaker 2+ platform for 3D 
printing. A total of 5 components (supplemental figure 1) were printed in less than 20 
hours. The syringe movement was then facilitated by the placement of linear bearings and 
rods (McMaster) inside components 1,2 and 3. The system was then mounted to a platform.  
3.1.3.5.  Flow control. To apply flow to vessels over a 24-hour timespan, a 
custom peristaltic pump system was built using an Arduino-based control system. A 
peristaltic motor (Welco) was controlled by an Arduino Uno (Arduino) and a motor board 
(Ada Fruit). A Sensiron flow sensor was used in-line of the perfusion system to monitor 
the applied steady flow rate. System schematics are shown in Supplemental Figure 2. The 
code to control the pump was written and compiled in Arduino IDE (Arduino) using open 
source libraries available within the IDE. To minimize pulsations in the system, a dampener 
was placed in series with the vessel. 
3.1.3.6.  Dynamic mechanical testing. Hydrogels with and without 
astrocytes were polymerized within the central reservoir of the microfluidic devices, and 
then removed after two days in static culture and transferred to a compression platen for 
axial dynamic mechanical testing (EZ-SX, Shiamadzu). Due to the fixed geometry of the 
microfluidic reservoir, all hydrogels had dimensions of 1-cm width, 1-cm length, and 1.6-
mm height. The hydrogels were compressed at a frequency of 0.5 Hz between 0 and 15% 
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strain in an unconfined configuration. The complex modulus was calculated by the ratio of 
the maximum stress and maximum strain. The phase shift between the stress and strain 
waveforms was used to determine the loss angle, and consequently the storage and loss 
modulus of the hydrogels. Three samples were tested for both cellular and acellular 
conditions (six total samples).   
3.1.4. RNA sequencing. 
 
3.1.4.1.  mRNA extraction. To measure gene expression profiles in the 
different flow regimes, channels were removed from the microfluidic devices after 24 
hours of flow and sectioned into disturbed, impinged, and fully developed regions based 
on their geometry using a razor. For each region, the endothelial cell layer was separated 
from the rest of the gel prior to RNA extraction. Two channels for each condition were 
required to produce a sufficient quantity and quality (RIN > 6.0) of mRNA. The mRNA 
was extracted using the PicoPure isolation kit. Twenty-one total channels were required 
for these experiments (three channels in duplicate for both steady and pulsatile flow 
besides three channels for static condition as a control). For quantitative and qualitative 
analysis, the Nanodrop spectrophotometer was used to measure the RNA concentration 
and quality. Quality was indicated by measuring the absorbance ratios (260/280). Ratios 
around 1.8 were classified as pure and therefore acceptable for gene sequencing. 
3.1.4.2.  Gene sequencing and Bioinformatics. The mRNA was shipped to 
an external company (GeneWiz) for next generation Sanger sequencing. To analyze the 
sequencing data, a group of open source bioinformatics software programs (FastQC, 
Trimmomatic, Htseq, STAR) along with a high-performance computing cluster (16 cores, 
60GB) was used to read the sequences and perform a quality control check, trim the bad 
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reads, align reads to the genome, and count the reads per gene. The disturbed, impinged, 
and static conditions were compared to the fully developed region as a reference. 
3.1.5. Polymerase chain reaction.  
 
3.1.5.1. Astrocyte message level quantification. After perfusion, hydrogels 
were removed from the microfluidic device and cut into regions representative of disturbed, 
impingement, and fully developed regions. mRNA from the astrocytes was isolated using 
PicoPure RNA Isolation kits (Thermo Scientific) and reverse transcribed to cDNA using 
qScript (Quantabio). Quantitative PCR was then performed with SYBR Green reagents, 
with the primers given in Table 1 used to amplify targets. Tests were conducted in triplicate 




 Primer sequences for astrocyte qRT-PCR 
Primer Forward Sequence Reverse Sequence 
 NONO GTGTAGCGTCGCCGTTACTC CCTTCATTTTGGCTGCTGGC 
VEGF GACATTGCTGTGCTTTGGGG AAGGGGAGCAGGAAGAGGAT 
HIF1a TGGCAACCTTGGATTGGATGGA CCGTCCCTCAACCTCTCAGT 





            Message levels were double normalized to Non-POU domain-containing octamer-
binding protein (NONO) from a collagen-only sample. Relative expression was quantified 
as 2-ΔΔCT where CT is cycles to threshold. Data are presented as the averaged fold change 
of collagen/HA gels compared to collagen only gels. 
3.1.5.2.  Endothelial cells message level quantification. After perfusion, hydrogels 
were removed from the microfluidic device and cut into regions representative of disturbed, 
impingement, and fully developed regions. mRNA from the endothelial cells was isolated 
using PicoPure RNA Isolation kits (Thermo Scientific) and reverse transcribed to cDNA 
using qScript (Quantabio). Quantitative PCR was then performed with SYBR Green 
reagents, with the primers given in Table 1 used to amplify targets. Tests were conducted 
















Primer sequences for endothelial qRT-PCR 
 
 
           Message levels were double normalized to Non-POU domain-containing octamer-
binding protein (NONO) from a collagen-only sample. Relative expression was quantified 
as 2-ΔΔCT where CT is cycles to threshold. Data are presented as the averaged fold change 
of collagen/HA gels compared to collagen only gels. 
3.1.5.3. Statistical analysis. The open source statistics package, R, was used 
to perform all statistical analysis. Edge R package was used to determine the differentially 
expressed genes. To get a sense on how correlated the samples are, a PCA (Principal 
Primer Forward Sequence Reverse Sequence 
   NONO  GTGTAGCGTCGCCGTTACTC CCTTCATTTTGGCTGCTGGC 
Lumican TCATCCCTGGTTGAGCTGGAT AGGATAATGGCCCCAGGATCT 
MMP1 AAAATTACACGCCAGATTTGCC GGTGTGACATTACTCCAGAGTTG 
 
MMP3 AGGACAAAGCAGGATCACAGTTG CCTGGTACCCACGGAACCT 
 
MMP10 TTACATTGCTAGGCGAGATAGG CAGTCACAGAACATGCAGGAA 
 




component analysis) was performed on the data to reduce the number of columns using the 
Variance, covariance, covariance matrix, eigenvalues and eigenvectors.   
3.1.6. Lumican knockdown. 
  
3.1.6.1. Lumican knockdown. Lumican knockdown was performed to alter 
its expression prior to flow experiments, using siRNA transfection with both a target 
sequence and scrambled sequence for a control. Cells were transfected using the 
appropriate protocol from Santa Cruz biotechnology. Briefly,cells were plated in a 6-well 
plate at 200k per well until they reached 60-80% confluency. A mixture of transfection 
reagent and transfection media was added to the transfection solution, and then to the 
cells. The transfected cells were incubated at 37 C for 6 hours, then the transfection 
solution was removed and replaced by EGM-2 for 24 hours prior to seeding.  
3.1.6.2. Western blot for transfection efficiency. Transfection efficiency 
was verified by western blotting: cells were lysed in sample buffer containing DTT and 
LDS, boiled, and loaded onto a gel and separated with electrophoresis. Proteins were 
transferred to a 0.45-µm PVDF membrane. Blots were quantified by measuring band 
intensity using ImageJ and normalizing relative expression to scrambled conditions. 
Membranes were incubated with anti-lumican (1:100, Santa Cruz, sc-166871) primary 
antibodies and visualized with HRP-conjugated secondary antibodies (1:4000, CST 
L27L9) 
3.1.6.3. Permeability testing. Following knockdown validation, twelve channels (n 
= 6 for knockdown, n = 6 for control) were exposed to steady and pulsatile flow for 24 
hours, and permeability experiments were conducted to evaluate the impact of lumican 
knockdown on barrier integrity by perfusing channels with 4KDa dextran.  
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3.1.6.4. Immunofluorescence. Four vessels were used in this section. Two vessels 
were perfused for 24 hours, and two others were transfected then perfused for the same 
period of time. Upon completion of the experiment, vessels were fixed in 4% 
paraformaldehyde (Alfa Aesar) for 30 min at room temperature. Following fixation, the 
top layer of the microfluidic device was separated using a razor blade, and the hydrogel 
was then removed from the device. Immunofluorescence was then performed after 
blocking in 3% BSA for 30 minutes at room temperature and incubating overnight at 4 C 
in a primary antibody for zonula occludin-1 (ZO1) (1:250, Cell Signaling Technology, 
Product 8193).Gels were then washed three times with PBS for 5 minutes and incubated 
in the appropriate secondary antibody (1:500, Santa Cruz, assorted), 1:500 Hoechst 
(Sigma), FITC-phalloidin (Life Tech, F432) and Lumican conjugated to Alexa 488 
(Santa Cruz sc-166871 AF488) for 1h at 37 C. Confocal stacks were acquired using a 
Nikon A-1 confocal scanning microscope.  
3.1.7. Monolayer experiments using flat gels.  
 
3.1.7.1.  Cell seeding and flow experiments. For the monolayer experiments, the 
same hydrogel formulation used in the annulus was polymerized on the treated PDMS 
coated plates under a sterile 40-mm glass coverslip to create a uniform circular hydrogel 
to replicate the fully developed flow and 12-mm glass coverslip for disturbed flow. 
Following removal of the cover slip, HCMEC/d3 were seeded on the gel at a density of 
4k/cm2 and allowed to adhere for 30 minutes prior to addition of EGM-2. Monolayers 
were incubated for 2 days in static culture to ensure confluency, then exposed to fluid 
shear stress. Fully developed fluid shear stress was applied using a 40-mm 1- degree cone 
plate on a rheometer (Waters) for 24-hrs on a Peltier plate set to 37oC. Shear stress 
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gradient was applied using a 40-mm flat plate to mimic the shear stress profiles 
experienced by disturbed flow. The media was supplemented with HEPES buffer to a 
final concentration of 10 mM to maintain pH and sterile Millipore was added to the plate 
during exposure of flow to counteract evaporative loss. 
3.1.7.2.  Lumican expression quantification. Lumican expression was performed 
using cell lysates extracted from cell monolayers cultured on the collagen hydrogels 
exposed to 24hrs of fully developed and disturbed fluid shear stress applied by a cone and 
plate rheometer. The gels for each condition were removed from the rheometer and 
washed immediately in ice cold PBS. The gels were then submerged in ice cold lysis 
buffer (CST) and sonicated. Gels were then spun down at 14,000 g for 5 minutes at 4oC. 
Supernatants were removed and snap frozen reserving a small aliquot for protein 
quantification. Samples were equilibrated at 0.5 mg/mL protein concentration using ice 
cold lysis buffer after thawing in a room temperature water bath. Samples were then 
loaded on a tris-acetate gel and separated using electrophoresis in tris-acetate buffer. 
Protein was transferred to a 0.45-µm PVDF membrane. The membrane was incubated 
overnight with Lumican antibody (1:100) (Santa Cruz, sc-166871) and visualized with 
HRP-conjugated secondary antibody (1:4000) (CST, L27L9). 
3.1.8. Small GTPase activity.  
 
3.1.8.1.  ELISA-based quantification of small GTPase activity. To determine the 
effect of lumican knockdown on small GTPase activity, commercial ELISA kits were 
purchased from Cytoskeleton (G-LISA) to quantify RhoA activation (Cytoskeleton). For 
the knockdown and scrambled control, cell lysates were prepared using Cytoskeleton’s 
protocols. Following exposure to flow, vessels were washed with ice cold 1x PBS for 30 
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seconds. In order to isolate sufficient protein quantity, endothelial cells lysates were 
prepared from two total vessels for each condition, therefore 100 µL of ice-cold cell lysis 
buffer with 1x protease inhibitor was injected into each vessel and collected in a 
microcentrifuge tube. The cell lysate solution was spun at 10,000 g for 1 minute at 4oC to 
pellet cell debris. The supernatant was collected and snap frozen in liquid nitrogen, 
reserving a small amount for protein quantification using Precision Red (Cytoskeleton). 
Prior to measuring GTPase activity, samples were thawed in a room temperature water 
bath and equilibrated to 0.8 mg/mL for RhoA samples. In order to complete these 
experiments in triplicate, a total of 12 vessels were fabricated for these studies (Six 
vessels for each condition).  
3.1.9. Lumican mechanics. 
 
3.1.9.1. Fibrillogenesis. Turbidity tests were conducted to assess the 
microstructure of collagen fibril formation and organization. Collagen fibril formation 
was measured as previously described100-102 at 340 nm in a UV sensitive 96-well plate in 
a plate reader. Each assay consisted of 100 μl of collagen at 20 mg/ml and variable 
concentrations of recombinant human lumican (VWR) 
(0.15mg/mL,0.5mg/mL,1.5mg/mL) using distilled water as diluent. All solutions were 
maintained at 4 °C. Collagen was added to the proteoglycan, mixed by pipetting and 
reading initiated immediately. Turbidity was measured every 2 min for 60 min. Readings 
were blanked against the diluent buffer and data were compared to collagen without 
recombinant lumican as a control.  Experimental turbidity curves were analyzed in terms 
of the maximum rate of turbidity change observed.  
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3.1.9.2. Rheology. To determine the impact of lumican on the mechanical 
properties of the ECM. Recombinant lumican was prepared and added to the collagen gel 
at different concentrations 102. Lumican-collagen composite gels was polymerized on a 
strain-controlled rheometer and the viscoelastic mechanical properties of the gels was 
assessed as a function of lumican concentrations. Both storage and loss moduli and loss 
angle were measured for a range of strain magnitude of 0.1% and frequency of 50 Hz, 
respectively. Data were compared to collagen without recombinant lumican as a control. 






4.1. Impact of Steady Disturbed Flow on Barrier Integrity  
 
4.1.1. Fabrication and characterization of a 3D in vitro model of a cerebral 
bifurcation.  A microfluidic device was designed to apply bifurcation flow profiles to a 
3D model of a cerebral artery, consisting of an endothelial intima and a smooth-muscle 
containing media layer surrounded by astrocytes. The device schematic in Figure 3A 
indicates the location of a 944-μm diameter endothelialized lumen surrounded by a 
smooth muscle cell-containing annulus with an outer diameter of 1.2 mm in a hydrogel 
seeded with astrocytes. To induce flow separation, defined as a disruption of a fully 
developed boundary layer, the flow inlet and cell-seeded vessel were offset by 45 
degrees.  Figure 3B shows a cross-section at the midpoint of the channel after 3 days in 
culture, indicating a confluent monolayer of GFP-positive endothelial cells (hCMEC/D3), 
an annulus of LifeAct-RFP expressing smooth muscle cells (hCMASMC), and an outer 
hydrogel of glial fibrillary acidic protein (GFAP)-positive astrocytes (NHA). Figure 3C 
provides a 3D reconstruction of the co-culture vessel, further verifying the stable 




Figure 3. Fabrication of a 3D cerebral bifurcation model. A) Schematic of the 
microfluidic device showing the location of the ports and the needle guides used to create 
the layered cell-seeded vessel, B) Cross-section of the vessel at its midpoint with GFP-
labelled endothelial cells (green), LifeAct-RFP smooth muscle cells (red), and GFAP-
positive astrocytes (magenta). scale = 100 m. The arrow indicates the flow direction. C) 
3D reconstruction of vessel scale = 100 m. D) Storage moduli (i), loss moduli (ii), and 
phase angle (iii) of hydrogels seeded with and without astrocytes. (n = 3) E) Astrocytes 
labeled with DAPI (blue), phalloidin (red), and anti-GFAP (green). F) GFP-labeled 
endothelial cells (green) exhibiting ZO-1 at cell-cell junctions (red). G) α-SMA-positive 







Preliminary flow tests in the microfluidic device revealed that astrocytes were 
needed within the hydrogel to prevent collapse of channels exposed to high flow rates. 
Given that previous studies have demonstrated that embedding astrocytes within 
collagen/hyaluronan composite matrices affects their viscoelastic properties103, we 
conducted dynamic mechanical testing of hydrogels with and without astrocytes. The 
compression testing indicated that hydrogels seeded with astrocytes featured an increased 
storage modulus (Fig. 3D,i), decreased loss modulus (Fig. 3D,ii), and reduced phase angle 
(Fig. 3D,iii) compared to acellular controls. This finding is consistent with our previous 
result that astrocytes alter the mechanical properties of a constrained collagen/hyaluronan 
hydrogel by exertion of cell-generated forces on the matrix103. Hence, astrocytes were 
required in the model not only to mimic the glial cells surrounding cerebral vasculature in 
vivo, but also to sustain forces exerted by high Reynolds number flow.  
 Immunofluorescence analysis using cell type-specific markers verified that the 
three cell types retained their phenotype after several days in the co-culture. Figure 3E 
shows the astrocytes within the outer hydrogel: the cells attached to the extracellular matrix 
and exhibited positive staining for GFAP, a marker of astrocyte activation. Figure 3F 
provides an image of the confluent endothelial monolayer lining the vessel lumen. After 
the application of flow, the endothelial cells exhibited localization of zonula occuldin-1 
(ZO-1) to the cell-cell junctions, indicative of tight junction formation. Finally, the smooth 
muscle cells within the annulus maintained their phenotype, as evidenced by positive 
staining for α-smooth muscle cell actin (α-SMA) (Fig. 3G).   
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4.1.2. Characterize the steady flow patterns inside the cerebral bifurcation 
using uPIV and CFD. Disturbed flow was defined by the disruption of a parabolic 
velocity profile characteristic of fully developed flow and the presence of a recirculation 
eddy caused by the separated flow. In the computational simulations, the eddy occurred 
on the near side of the cell-seeded vessel directly downstream of the bifurcation. The 
location along the wall where the wall shear stress was equal to zero was designated as 
the stagnation point of the flow. The computational model determined the flow rate that 
assured the location of the stagnation point was consistent for all geometries, in order to 





Figure 4. Flow characterization of the bifurcation.  A,i) Velocity contour plot generated 
with the CFD software using a flow rate of 4 mL/min. A,ii) A radial velocity plot in the 
disturbed region (purple dotted line) and A,iii) fully developed region (purple solid line). 
B) Velocity contour plot within the boxed region of panel A. C) Velocity contour plot 
measured with microparticle image velocimetry and processed with a MATLAB code. D) 
Velocity profile along the channel radius at x= 0.18 mm E) x= 0.33mm, F) x= 0.55mm 
and, G) x= 1 mm. Error bars indicate the standard deviation between 20 frames. 
 
 
             A 3D computational fluid dynamics (CFD) model was constructed to characterize 
the flow within the microfluidic device and to determine the flow rate required to cause 
flow separation along the cell-seeded vessel. A brightfield image of the channel geometry 
was imported into SolidWorks, discretized, and meshed using a commercial CFD code 
(Star CCM+). The CFD model predicted flow separation at the near wall of the cell-seeded 
vessel for an input flow rate of 4 mL/min (Fig. 4A,i). At this location, the velocity profile 
was no longer parabolic and a recirculation eddy was present. The flow reattached to the 
wall 2.2-mm downstream of the vessel inlet, as evidenced by the onset of constant wall 
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shear stress and a fully developed velocity profile. Radial velocity plots in the disturbed 
(Fig. 4A,ii) and fully developed (Fig. 4A,iii) regions indicated the flow separation caused 
by the bifurcation. A velocity contour at the bifurcation (Fig. 4B) further exhibited the 
asymmetric flow profile and separation from the near wall of the cell-seeded vessel. 
 In order to validate the computational model, microparticle image velocimetry 
(PIV) was used to quantify the velocity profile within the vessel. Flow was applied at the 
4-mL/min rate used in the computational model, and the velocity contour was measured 
within the cell-seeded vessel. As Figure 4C indicates, PIV demonstrated a similar region 
of separated flow at the inlet of the cell-seeded vessel as the computational model (Fig. 
4B). At four distances from the inlet of the cell-seeded vessel (x = 0.28 mm, 0.33 mm, 0.55 
mm, and 1 mm), the velocity profiles predicted by the computational model were compared 
to the measurements from the PIV measurements (Fig. 4D-G). The plots indicate close 
agreement between the predicted velocity distributions and those measured by PIV. For 
most data points, the computational value falls within one standard deviation of the 
experimental measurement, with the exception of the contour at x = 1-mm (Fig. 4G) where 
the computational model overestimates the velocity measured experimentally at radial 
distances varying from 0.2 to 0.5-mm. A possible cause for this discrepancy is small 
variations in channel geometry caused by perfusion. To interrogate the effect of perfusion 
on channel geometry, the deformation of the channel walls was measured during the 
application of 4.5 mL/min flow and found to increase by 0.5 +/- 0.01% on average along 
the channel length (measured in three locations for three separate channels). The deformed 
geometries were then input into the computational model to determine its effect on 
predicted velocity distribution at x = 1-mm. As Supplemental Figure 3 indicates, changes 
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to the wall geometry caused by perfusion do not substantially alter the wall shear stress 
along the channel, suggesting that another factor is likely responsible for the discrepancy 
in Figure 4G. Nonetheless, the maximum velocity and asymmetry of the distributions were 






Figure 5.Generalized model to account for geometric variation: A) Schematic of the 
bifurcation detailing the parameters used to quantify differences in vessel geometry. B) A 
brightfield image indicating the location of these parameters in a sample vessel. C) Wall 
shear stress profiles generated with CFD for three different geometries and flow rates 
varying from 4-4.5mL/min. D-F) comparison plots between the experimental and 
measured wall shear stress (WSS) profiles along a 1.2-mm length of the near wall of the 





 Having demonstrated the efficacy of the computational model to predict velocity 
distributions within the device, additional work was conducted to assure that reproducible 
flow profiles could be applied to multiple channels despite small differences in channel 
geometry caused by the placement of needles within the hydrogel. Therefore, in order to 
create a repeatable system for cell studies, an approach was developed to normalize the 
flow fields for varying geometries. Specifically, the computational model was used to 
determine the flow rate required to fix the location of the flow stagnation point (where wall 
shear stress was equal to zero on the near side wall) at the same distance from the inlet 
regardless of the channel geometry. Four parameters were used to describe the channel 
geometry prior to application of flow, depicted in Figures 5A and 5B. These parameters 
provided insight into the position of the hydrogel within the microfluidic device in order 
to account for slight differences in the placement and orientation of the cell-seeded vessels. 
Parameters A and B indicated the extent to which the channel was centered within the 
device, and Parameters C and D described the lateral placement of the hydrogel. Table 2 
summarizes the values of these four parameters for three different channel geometries 
(Geometry 1, Geometry 2, and Geometry 3). 
            For the three geometries, the average and standard deviation of the stagnation point 
was predicted to occur at 0.543 mm +/- 0.029 mm and the length of the disturbed region 
was 2.17 mm +/- 0.44 mm for flow rates varying from 4 to 4.5 mL/min. The predicted 
shear profiles along the near-side wall of the vessel are shown in Figure 5C. Due to the 
changes in flow rate, the average shear stress among the three geometries in the fully 
developed region downstream of the bifurcation was 0.835 Pa +/- 0.056 Pa, which is 
consistent with physiological levels for the middle cerebral artery 104. PIV was used to 
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validate the shear stress profiles for the three geometries along a 1.2-mm-length of the 
channel adjacent to the bifurcation on the near wall (Figs. 5D-F). The plots show close 
agreement between the predicted shear stress distributions and those measured by PIV. 
Importantly, the distributions all indicate substantial recirculation zones and a similar 
stagnation point for all three geometries. These results verify that the stagnation point of 
the flow can be fixed regardless of small changes to vessel geometry, allowing for a 
reproducible flow environment for studying the endothelial response in multiple samples.  
4.1.3. Evaluate the impact of flow regimes on the BBB integrity.  
 
4.1.2.1.  Effects of disturbed fluid flow on endothelial tight junctions and 
morphology. Having demonstrated that disturbed flow could reproducibly be applied to 
the vessels despite inconsistencies in channel geometry, experiments were conducted to 
assess the effect of disturbed flow on the integrity of tight junctions within the endothelial 
monolayer. In vitro vessels were either exposed to flow for 24-h with flow rates that caused 
flow separation at the location of the bifurcation or cultured in static conditions as an 
additional control. Imaging of the monolayer exposed to static conditions revealed that ZO-
1 was not fully localized to cell-cell junctions (Fig. 6A,i-ii). In contrast, endothelial cells 
exposed to fully developed flow exhibited ZO-1 localization to the cell-cell junctions (Fig. 
6B,i-ii). In the disturbed region, images of the endothelium at the stagnation point indicated 
a disorganized monolayer with substantially less ZO-1 staining at the junctions (Fig. 6C,i-
ii). FFT analysis suggested that the cells in the fully developed region were significantly 
more aligned in the direction of flow than cells in the disturbed region (Fig. 6D-E). To 
provide further evidence of tight junction formation and disruption in these different 
regions, vessels were also treated with antibodies for claudin-5 and occludin, two 
43 
 
additional markers for the tight junctions that are characteristic of the BBB. These images 




Figure 6. Effects of disturbed flow on endothelial cells tight junctions: A-C) Composite 
images of ZO-1 (red), DAPI (blue), and phalloidin (green) (i) and with ZO-1 isolated (ii) 
of the endothelial cells along the near side wall in static conditions (A) and in 
perfusedchannels at the fully developed (B) and stagnation point of the disturbed region 
(C). Scale for A-C: 25 m D) Gaussian distribution of the actin fibers fitted to results of 
FFT analysis. E) Width at half height of the distributions for disturbed and fully 





4.1.2.2 Effects of disturbed fluid flow on endothelial cell proliferation and 
viability. As shown in Figure 7, the endothelium in the disturbed region appeared to have 
a higher cell density than the region in the fully developed region downstream of the 
bifurcation. To determine whether disturbed flow augmented proliferation in the 
disturbed region, a BrdU assay was conducted to compare the number of cells in S-phase 
between the disturbed and fully developed regions. Based on channel geometries, flow 
rates were chosen to match the wall shear stress distributions used in the 
immunofluorescence and permeability assays and applied for 24-h. After 12-h, BrdU was 
added into the perfusing medium. Imaging of the fully developed region showed few 
BrdU-positive nuclei (Fig. 7A) In contrast, the disturbed region (Fig. 7A) exhibited an 
increased number of BrdU-positive nuclei (and higher number of nuclei overall) at the 
location of the stagnation point of the near wall (Fig. 7B). Quantification of the disturbed 
and fully developed regions indicated a significant increase in the number of BrdU-
positive cells. In the disturbed region: 65% of cells were in S-phase compared to only 3% 
in the fully developed region (Fig. 7C). This result is consistent with previous studies that 
found increased endothelial proliferation is associated with barrier breakdown 105. 
           To verify that endothelial cell viability was not affected by the different flow 
regimes, a Live/Dead assay was conducted for static,disturbed, and fully developed 
conditions. Across all conditions, the viability exceeded 92% regardless of the shear stress 
exerted on the endothelium. Furthermore, there were no significant differences in the 
number of viable cells between static (Fig. 7D,i), fully developed (Fig. 7D,ii), and disturbed 
(Fig. 7D,iii) conditions.  Figure 7E provides a summary of the quantified data, indicating 
no significant difference in viability between the different flow regimes. These results 
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indicate that although cells in the disturbed region proliferated at a higher rate, they 





Figure 7. Effects of disturbed flow on endothelial cell proliferation and viability: A-B) 
DAPI (i) and BrdU (ii) staining of the endothelial lumen for fully developed (A) and 
disturbed (at the stagnation point of the near wall) (B) regions. Scale bars = 25 m. C) 
Percent of BrdU-positive nuclei (n=3). *indicates p < 0.05. D) Live (green) / Dead (red) 
assay for cells exposed to static (i), fully developed (ii), and disturbed (iii) flow. Scale bars 
= 100 m. E) Quantification of Live/Dead assay for three different vessels for each 




4.1.2.2.  Quantification of vessel permeability and endothelial-mural/endothelial-
glial interaction. Permeability testing provided a quantitative means to assess the integrity 
of the barrier in response to varying flow regimes. Devices were perfused with dextran to 
quantify barrier integrity after 24-h of perfusion. The permeability coefficient was 
measured at the fully developed region downstream of the bifurcation (I) and at the near 
wall (where flow separates) (II) and far wall (III) adjacent to the bifurcation in the area of 
disturbed flow. Figure 8A provides an image of a vessel being perfused with dextran to 
assess barrier permeability and denotes the three regions where the permeability was 
measured. Figure 8B indicates that the permeability is significantly higher in not only the 
near wall of the disturbed region (II) compared to the fully developed region (I), but also 
at the far wall of the disturbed region (III). At this location, the vessel wall experiences 
impingement flow: the shear stress was elevated compared to other regions of the vessel 
(1.4 Pa +/- 0.22 Pa) and the shear varied along the axial direction of the vessel. This result 
supports previous studies linking impingement flow 106 and high shear stress 106 to vascular 
dysfunction in the brain. In order to verify that the increased dextran transport adjacent to 
the bifurcation was not due to leakage from the side of the hydrogel, the gradient of 
fluorescence intensity was graphed in both the axial and radial direction for the disturbed 
region. Measurements indicate that there is no gradient of fluorescence along the axial 
direction, indicating that the transport of dextran into the hydrogel originates from the 
disturbed portion of the cell-seeded vessel. Overall, these permeability tests verify the 




Figure 8. Effect of disturbed flow on vessel permeability and smooth muscle cell and 
astrocyte interaction. A) An image of dextran perfusion indicating the location of 
permeability measurements: I) Fully developed, II) Disturbed on the near side wall 
(separated flow),III) Disturbed on the far side wall (impingement flow). B) 
Quantification of the permeability constant at these three regions and a static control. (n = 
3) C) Quantification of permeability coefficients for vessels lacking smooth muscle cell 
incorporation. (n = 3) D) A representative image of smooth muscle cell orientation along 
the endothelialized vessel. E) Relative gene expression of GFAP, HIF1alpha, and VEGF 
of astrocytes isolated from regions adjacent to endothelial cells exposed to fully 
developed (I), disturbed (II), impinged flow (III), and static conditions. (n = 3) * indicates 





In order to probe endothelial-mural crosstalk, permeability tests were repeated on 
vessels with smooth muscle cells removed from the annulus.  Given the effect of mural 
cells on regulation of vascular tone107, lipid absorption108, and small GTPase signaling 
within endothelial cells 109, these experiments interrogated whether smooth muscle cells 
also influenced the response of the BBB to altered shear stress. Figure 8C indicates that the 
absence of smooth muscle cells did not cause a significant effect in the permeability of the 
endothelium in the disturbed and fully developed regions. Additional imaging experiments 
were conducted to determine if the spatial organization of the smooth muscle cells varied 
along the vessel (Fig. 8D). Quantification of the distance between smooth muscle cell 
nuclei and the endothelial lumen indicated no significant difference between disturbed and 
fully developed regions.  
Astrocytes in regions adjacent to the three flow regimes (I: fully developed, II: 
disturbed, and III: impinged) were isolated and lysed following application of flow to 
determine whether glial cells mediated barrier disruption by undergoing activation or 
increasing gene expression of paracrine factors known to cause barrier breakdown. 
Although gene expression does not elucidate the underlying mechanisms regulating the 
response of astrocytes to their environmental factors, this assay provides insight into 
whether the flow regime affected the astrocyte cell response. Message level quantification 
indicated no significant difference in the production of GFAP, which is indicative of glial 
activation, or in the production of paracrine factors VEGF and HIF1α, which are known to 
modulate vascular integrity and function. These results verified that astrocytes surrounding 
the endothelium exposed to different flow regimes did not affect barrier integrity by 
altering their gene expression.  
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4.2. Impact Of Disturbed Pulsatile Flow On The Integrity Of The BBB 
 
4.2.1. Pulsatile flow generation within the 3D bifurcation model. The 
perfusion system portrayed in (Fig. 9 A-C) was designed to generate pulsatile, separated 
flow waveforms inside a 3D vessel model by superposing oscillations on the constant 
mean flow generated by the peristaltic pump. A flow sensor was placed directly 
upstream of the channel to measure flow rates (Fig. 9A). The linear actuator was 
programmed to recreate the physiological flow waveform depicted in Figure 9D, 
exhibiting four inflection points: (1) peak systolic pressure (2) reflected peak; (3) 
dicrotic notch, and the (4) following peak [150]. This waveform was applied at a 






Figure 9. Pulsatile flow system design. A) Photograph of the perfusion system with the 
peristaltic pump for steady flow generation and the Linmot oscillator for pulsatile 
superposition. B) Schematic showing the flow circuit used to generate the flow 
waveform. C) Plot of the physiological-like flow waveform generated with the perfusion 
system showing the four characteristic points (1) peak systolic pressure; (2) reflected 
peak, (3) dicrotic notch, and the (4) following peak. Dii) Comparison of the physiological 




4.2.2. Pulsatile flow characterization within the 3D vessel model using PIV 
and CFD. In order to characterize the flow regimes within the 3D vessel model, 
brightfield microscopy was used to measure the channel dimensions and orientation 
using a previously described method 98. The geometry was imported into SolidWorks 
(Fig. 8A) and then discretized with a polyhedral mesh (Fig. 10Bi,Bii) using a 
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commercial computational fluid dynamics (CFD) code (Star CCM+). The CFD model 
predicted separated flow regions at the near wall of the channel at the systolic peak and 
the dicrotic and anacrotic notches (Fig. 10C-E), characterized by flow recirculation near 
the wall. However, in the diastolic point, no recirculation eddies were present. Overall, 
the computational model found a time-dependent velocity changing in direction and 
magnitude during the course of the waveform.  
Microparticle image velocimetry (PIV) was used to quantify the time-dependent 
velocity profiles within the channel and validate the computational model. Pulsatile flow 
was applied to the channel using the same waveform utilized in the CFD model, and the 
velocity contour plots were calculated within the channel at the four characteristic time 
points (Fig.9D). As Fig. 10C-F indicate, PIV demonstrated a similar region of separated 
flow at the inlet of the channel as the computational model for the points 1,2 and 4. 
However, both approaches confirmed there was no backflow measured at the wall. These 
results demonstrate that the flow rate is the key parameter governing the flow patterns 
within the channel. Therefore, the flow was causing recirculation eddies at high Reynolds 
numbers (112, 133 and 306) in the dicrotic notch, the anacrotic notch and the systolic 
peak respectively. On the other hand, Reynolds number below 100 (92 at the diastolic 






Figure 10. CFD velocity contour plots validated by microPIV along one cycle of the 
waveform. A) A SolidWorks image of the channel geometry highlighting the hydrogel 
positioning within the channel, B) Polyhedral mesh generated for the CFD model along 
with the prism layers along the wall. C) Velocity contour plot at the systolic point 
generated with the CFD and PIV, D) Velocity contour plot at the dicrotic notch 
generated with the CFD and PIV. E) Velocity contour plot at the diastolic point 
generated with the CFD and PIV and, F) Velocity contour plot at the anacrotic notch 





          Comparing velocity profiles at three different axial positions provide a means to 
more quantitatively assess the velocimetry validation of the CFD model. The axial 
positions include x  = 0.2 mm, 0.6 mm, and 1 mm from the inlet of the cell-seeded channel. 
The plots in Fig. 9 confirm that at a distance of x = 1 mm from the inlet, the flow remained 
disturbed for the systolic point and the dicrotic and anacrotic notches, evidenced by the 
lack of a parabolic velocity profile and the negative velocity along the near wall. At the 
disastolic point, the flow was not fully developed, but the boundary layer on the near wall 
was not as substantially affected. However, for the diastolic point, while the velocity plot 
exhibited an asymmetric profile and the flow was not fully developed yet, there was no 
recirculation at the near wall of the channel, evidenced by the positive velocity values. The 
radial velocity plots in the flow separation region (Fig.11 A,B,D)) indicated the flow 
separation caused by the bifurcation in the peak systolic, the diacrotic notch and the 
anacrotic notch. 
          For most data points, the computational values fall within one standard deviation of 
the experimental measurement. While the peak systolic was characterized by minor 
discrepancies between the experimental and computational results, the maximum velocity 
and the asymmetry of the profile from both approaches were consistent. Conversely, the 
velocity comparisons in the diastolic and the dicrotic and anacrotic notches reveal close 
agreement between the predicted velocity distributions and those measured by PIV with 
minimal variations between the 5 PIV measurements. Overall, these results 





Figure 11. Temporal-spatial matrix of velocity profiles in the bifurcation model., Ai) 
Velocity profile at the systolic point along the channel radius at x= 0.2 mm Aii) x= 
0.6mm, Aiii) and,  x= 1mm., Bi) Velocity profile at the dicrotic notch along the channel 
radius at x= 0.2 mm Bii) x= 0.6mm, Biii) and, x= 1mm. Ci) Velocity profile at the 
diastolic point along the channel radius at x= 0.2 mm Cii) x= 0.6mm and, Ciii) x= 1mm., 
Di) Velocity profile at the anacrotic notch  along the channel radius at x= 0.2 mm Dii) x= 







4.2.3. Measurement and validation of wall shear stress profiles along the near wall.  
In addition to the velocity profiles, the computational fluid dynamic model (CFD) 
predicted periodic changes in the instantaneous wall shear stress at different time points 
of the cycle in the bifurcation model. Furthermore, these periodic changes resulted in 
varying stagnation points along the channel wall which varied from 0.543 mm for the 
systolic point (Fig. 12A) to 0.38 mm for the dicrotic and anacrotic notches (Fig. 12B, C). 
As evidenced by the positive wall shear stress profile in Figure 12.D, no reattachment 
point was observed in the diastolic flow due to the absence of recirculation at that time 
point of the waveform. The PIV validated the wall shear stress profiles along 
approximately a 1.2-mm-length of the channel adjacent to the bifurcation on the near wall 
for the four different time points of the flow waveform. The plots showed close 
agreement between the CFD-predicted wall shear stress profiles and those measured by 
PIV, and verified that the systolic, dicrotic and anacrotic notches exhibited recirculation 
regions at the near wall of the channel. In addition, the spatial and temporal 
characteristics of the wall shear stress distributions were consistent with the measured 




Figure 12. Wall shear stress profiles along the near wall of the bifurcation model A-D) 
comparison plots between the experimental and measured wall shear stress (WSS) profiles 
along a 1.2-mm length of the near wall of the disturbed region for the four different time 
points systolic point, the dicrotic notch, the diastolic point and ,the anacrotic notch in the 




4.2.3. The impact of pulsatile flow on endothelial cells tight junctions and 
barrier permeability. Having demonstrated the ability to apply pulsatile flow in the 
cerebral bifurcation model, channels were perfused with pulsatile flow for 18h to assess 
the effect of disturbed flow on the integrity of the blood-brain barrier and endothelial 
cells tight junctions. Confocal images of the vessel revealed that ZO-1 was not fully 
localized to cell-cell junctions (Fig. 13D-E), in the disturbed region with an increased 
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stress fiber formation within the cells (Figure 13F). In contrast, endothelial cells exposed 
to fully developed flow exhibited ZO-1 localization to the cell-cell junctions (Fig. 13A-
C) and appeared to be aligned to the flow direction. Alignment quantification was 
verified by the Fast Fourier Transform (FFT) analysis. Results demonstrated that the cells 
in the fully developed region were significantly more aligned in the direction of flow than 
cells in the disturbed region (Fig. 13G-H). To determine whether the morphological 
changes affected barrier integrity,.permeability tests were performed. Three vessels were 
perfused with Dextran after 18 h of pulsatile flow perfusion.  The permeability coefficient 
measured at the fully developed region was significantly lower than the one measured at 
the near wall where the flow separates (Figure 31.I). These results do not contradict our 
previous study on the impact of steady disturbed flow on the BBB integrity inside a 3D 
cerebral vasculature model. However, a transcriptional analysis is further needed to better 
understand the mechanism by which endothelial cells respond to the different natures of 




Figure 13. Impact of pulsatile flow on the BBB integrity: A) Composite images of Zo1 
staining(red), DAPI (blue) and phalloidin (green) for channels exposed to fully developed 
flow, B) Zo1 channel isolated for channels exposed to fully developed flow, C) actin 
channel isolated, D) Composite images of Zo1 staining(red), DAPI (blue) and phalloidin 
(green) for channels exposed to disturbed flow, E) Zo1 channel isolated for channels 
exposed to disturbed flow ,F) actin channel isolated, G) FFT pixels , H) width at half 
height of the distributions for the fully developed and disturbed flow regions and I) 
Permeability coefficient quantification for the fully developed and disturbed regions. 
Arrows indicate the direction of flow. Scale bar: 50 um. * p < 0.05. 
 
4.3. RNA Sequencing 
 
4.3.1 General approach. Given the 944-m diameter of the vessel and a cell 
density measured to be 182,430 cells/cm2 +/- 30,230 cell/cm2 on the near side of the 
vessel, these studies suggest that 10,000-12,000 cells are exposed to separated flow in 
59 
 
each experiment. To verify that this number is sufficient to conduct gene expression 
analysis, mRNA was extracted from approximately 2-mm long regions of two separate 
vessels exposed to disturbed,impinged flow, in addition to regions exposed to fully 
developed flow. With the exception of the static condition, the three flow conditions were 
derived from the same channels. These isolates exhibited sufficient quality for RNA-
sequencing (RIN > 6.0). To analyze the sequencing data, the raw file (Fastq files) were 
imported in the FASTQC software to check the read quality. All bad reads (not satisfying 
the Q30 threshhold) were trimmed using the trimmomatic Software. The reads were then 
aligned to the genome using the STAR software. Finally, HTseq was utilized to assign 
the aligned reads to genes.  
4.3.1. Results. 
 
4.3.1.1.  Steady flow results.  
4.3.1.1.1. Principal component analysis. Differential gene analysis between 
regions of the vessel exposed to disturbed, fully developed, impinged flow was 
completed in addition to static conditions as control. To gain a better understanding of the 
difference in gene expression between these groups, principal component analysis was 
conducted using the results of RNA sequencing.  Results (Figure 14.A) shows that the 
data clustered in a shear dependent matter for the four different conditions. The static 
condition is clustered in a region separate from the cells exposed to flow. This analysis is 
repeated in Figure 14.B focusing on only fully developed and disturbed conditions, again 
showing the clustering of these two groups. The principal component (PC1) shown in the 
fully developed – disturbed comparison accounts for 80% of the variation in the data, as 






Figure 14. Principal component analysis of the flow conditions. A) plots the data along 
two components that show separation between the flow groups and static condition, as 
well as differences between the flow regimes. B) plots focusing on fully developed and 
disturbed conditions along two components. C) Percent variation plot for the analysis of 




4.3.1.1.2. Differential gene expression analysis.  The bioinformatics analysis 
found differences in gene expression between the disturbed and fully developed regions 
with 645 downregulated and 1040 upregulated genes respectively in the disturbed 
compared to the fully developed region. The heatmap plot (Fig.15A) shows the 20 most 
variable genes between the two different regions. Among these genes, the matrix 
metalloproteinases MMP1, MMP3, MMP12 as well as lumican; a member of the small 
leucine-rich proteoglycans (SLRPs) were shown to be significantly downregulated in the 
disturbed region as validated by qrt-PCR (Fig 15.B). Lumican, which has been implicated 
in ECM organization and collagen fibrillogensesis 111-113, had a 10-fold increase in 
expression in the fully developed region compared to the disturbed region. Furthermore, 
lumican expression has been shown to regulate the activation of  RhoA through multiple 
interactions with Rho-GEFs, Rho-GAPs and their effectors in lung cancer 114. Therefore, 
these initial studies not only demonstrate the validity of this approach, but also underscore 
the potential of this model to investigate the effects of disturbed flow on the endothelial 
cells within the BBB. The heatmap plot (Fig.15A) confirms the differentially expressed 





Figure 15. Differential gene expression analysis: A)Heatmap plot showing the difference 
in expression of genes in the fully developed and disturbed regions using  RNA 
sequencing. B) Message level analysis of five most differentially expressed genes 
identified usingqrt-PCR for vessels exposed to steady flow.  
 
 
4.4. Impact of Lumican Knockdown On The Integrity Of The Barrier In The 
Endothelium Exposed To Steady Flow 
 
            Experiments were conducted to determine whether knocking down lumican in 
cells exposed to fully developed flow would also cause barrier breakdown, to establish 
lumican as an important component of barrier formation and maintenance. 
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4.4.1. Impact of disturbed flow on lumican localization. To further validate 
the RNA sequencing results, immunofluorescence was utilized to qualitatively compare 
the levels of lumican protein expressed by endothelial cells in the disturbed and fully 
developed regions. Figure 16 shows that the lumican expression in the fully developed 
region is spread more diffusely throughout the cell, while cells exposed to disturbed flow 
exhibited substantially more perinuclear staining. These images also show the difference 
in ZO-1 staining between fully developed and disturbed regions, supporting previous 
results. 
 
Figure 16.  Impact of flow on Lumican expression. A) Immunofluorescence of 
endothelial cells in fully developed and disturbed regions. DAPI (blue), anti-ZO-1 (red), 
and anti-lumican (green) are shown. The right-side panels remove the DAPI stain to show 
the difference in perinuclear staining between conditions. Scale 25um, B) Quantification 
of lumican expression in flat gels exposed to fully developed and disturbed flow 




          To further determine whether the protein expression of lumican mirrors the 
transcriptional changes, lumican expression by endothelial monolayers exposed to fully 
developed and disturbed shear stress profiles using a rheometer was quantified using 
western blot. Results showed that lumican expression in gels exposed to disturbed shear 
stress profiles is significantly lower than those of fully developed flow further validating 
that disturbed flow alters the expression of lumican.  
4.4.2. Impact of lumican knockdown on the barrier integrity.  
 
4.4.2.1. Lumican knockdown verification. Due to the length of time between 
when the channel is seeded with endothelial cells and the permeability of the vessel is 
measured (5 days), the siRNA knockdown efficiency was evaluated at day 5 post-
transfection. The knockdown efficiency was verified using western blotting with anti-
lumican primary antibodies and HRP-conjugated secondary antibodies. Western blotting 
validated the effect of gene editing on Lumican expression. Figure 17 shows that the 
siRNA is approximately 44% efficient in knocking down lumican expression in the 












4.4.2.2. Impact of lumican knockdown on the barrier integrity under steady and 
pulsatile flow conditions. Two conditions (knockdown and control) were evaluated to 
determine whether depletion in Lumican impacted he barrier integrity for the steady and 
pulsatile flow conditions. Immunofluoresence staining showed that the knockdown 
affected the expression of ZO-1 (red) (green) which was markedly different from the 
control cells. Vessels treated with scrambled guide sequences were not affected by 
transfection, ZO-1 is observed at the cell-cell junctions with minimal perinuclear 
localization. Figure 18.A illustrates the difference in ZO-1 localization to cell-cell 
junctions in scrambled and knockdown conditions. The knockdown condition resembles 
the cells exposed to the disturbed flow regimes, indicating substantial barrier breakdown. 
The immunofluorescence studies were validated by dextran permeability quantification. 
Knocking down lumican expression drastically altered the barrier response to fully 
developed flow under steady and pulsatile flow conditions. Figure 18.B finds that using 
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siRNA to knockdown lumican expression significantly increases the permeability to 4-
kDa FITC-labeled dextran. While the permeability of knockdown vessels is not 
statistically different from vessels exposed to the disturbed flow regimes in the steady 
flow condition (Fig 18.C), the permeability coefficients for the knockdown and disturbed 
flow region in the pulsatile flow condition were statistically different (Fig 18.D). 
Altogether, these results indicate that lumican plays an important role in regulating 




Figure 18. Impact of lumican knockdown on barrier integrity for steady and pulsatile 
flows A) Immunofluorescence of scrambled and knockdown conditions in the fully 
developed flow regime. B) Permeability coefficients calculated from 4-kDa FITC dextran 
for steady flow and  pulsatile flow conditions, C) Comparison of permeability 
coefficients between scrambled control and fully developed flow conditions and 
knockdown and disturbed conditions for the steady flow, and D) Comparison of 
permeability coefficients between scrambled control and fully developed flow conditions 
and knockdown and disturbed conditions for the pulsatile flow. 
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4.4.2.3. Impact of lumican knockdown on fluid shear stress 
mechanotransduction. Previous studies have found that lumican expression alters 
Rho/ROCK activity, therefore cells treated with knockdown and scrambled siRNA were 
seeded into channels and exposed to flow prior to measurements of barrier integrity. 
Studies were conducted to determine the effect of shear stress on RhoA activation within 
the 3D BBB model. ELISA assays provided further insight into the effect of flow on the 
activation of small GTPases. 
 
              




           Figure 19 shows that there is no statistical difference between the knockdown and 
scrambled control in the level of RhoA activity, as measured by ELISA assay. Although 
lumican has a substantial impact on barrier breakdown, these assays indicate that lumican 
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does not contribute to changes in RhoA activation suggesting that other specific 
components of the mechanosensing complex are associated with the blood-brain barrier 
response to fluid shear stress in the cerebral artery.  
4.5. Lumican Mechanics  
 
           In order to determine whether lumican alters the mechanics of the surrounding 
ECM, rheological characterization was conducted to determine whether the presence of 
the proteoglycan would affect polymerization and viscoelastic properties of a collagen 
hydrogel. 
4.5.1. Turbidity assays and rheology results. The addition of lumican was 
shown to increase the stiffness of the gel compared to collagen without lumican (Fig. 
20A). However, lumican increases the time required for the gel to polymerize in a dose 
dependent manner, indicating that lumican alters crosslinking process. Fibrillogenesis 
assays confirmed the effect of the proteoglycan. Initially, the impact of recombinant 
lumican on collagen fibril formation was measured for three different lumican 
concentrations (0.01 mg/mL, 0.05mg/mL, and 0.075 mg/mL) (Fig 20.D). Lumican was 
shown to have an impact on collagen fibrillogenesis compared to the control sample 
lacking the lumican. Results showed that the addition of lumican increased the time taken 
before initial fibril formation happened compared to control conditons (collagen only). 
Therefore, lumican slows down fibrillogenesis with a lower fibril formation plateau. At 
the end of fibrillogenesis, lumican resulted in overall reduced turbidity indicating a lower 
fibril diameter compared to the control condition in addition to enhancing collagen fibril 
stability. These findings suggest that lumican stabilizes the fibril and limits fibril growth 
which is consistent with previous studies100. Therefore, this would reduce rearrangement 
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Figure 20. Impact of lumican proteoglycan on collagen fibrillogenesis and mechanical 
properties. A) Storage moduus of collagen, and collagen-lumican mixtures, B) Loss 
modulus of collagen, and collagen-lumican mixtures, C) Impact of lumican on collagen 








5.1. Disturbed Flow Disrupts The Blood-Brain Barrier In A 3D Bifurcation Model 
 
These results reinforce the growing evidence that fluid shear stress modulates the 
integrity of the BBB. Whereas a previous study from one of our groups demonstrated the 
protective effects of low levels of shear on the BBB15 , here, our findings indicate that shear 
stress altered by disturbed flow has the opposite effect. Endothelial cells within the region 
of separated flow exhibit altered morphology, increased permeability, and higher 
proliferation rates compared to cells in the fully developed flow region downstream of the 
bifurcation. Although previous studies have identified similar consequences of disturbed 
flow in other parts of the body54, the current findings show that vasculature in the brain is 
also impacted by the altered shear stress exerted by separated flow. Because the barrier 
function of brain vasculature is more vital than vasculature in other regions of the body due 
to the inflammation caused by the leakage of plasma components into the brain 
parenchyma, these results underscore the impact of disturbed blood flow in the brain. 
Additionally, given that recent studies115, 116 have found transcellular breakdown precedes 
the paracellular transport measured here, the effect of disturbed flow on the barrier may be 
even more pronounced than our experiments indicate. 
The results also demonstrate that the cerebral bifurcation model provides a robust 
platform to study the response of brain vasculature to complex fluid mechanics. Unlike 
previous in vitro models designed to exert disturbed flow on endothelial cells, the current 
model preserves the three-dimensionality of the in vivo environment and incorporates both 
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mural and glial cells in the surrounding hydrogel. Although our results suggest that smooth 
muscle cells and astrocytes do not modulate the endothelial response to disturbed flow, 
these findings do not contradict previous findings on the importance of endothelial-mural 
and endothelial-glial crosstalk. Rather, the results indicate that the endothelium modulates 
tight junction integrity in response to fluid shear stress independent of other cell types, 
which is consistent with a previous finding that cerebral endothelial cells exposed to shear 
stress form tight junctions in the absence of astrocytes15. Although the model mimics 
certain aspects of in vivo vasculature that have yet to be incorporated in vitro, it does not 
fully recreate the in vivo microenvironment and focuses on a rather short (24-hour) time 
frame. There are differences in both the ECM content (brain tissue contains minimal 
fibrillar collagen type I) and a lack of cell types including microglia, pericytes, and 
macrophages that could affect the specific range and magnitude of shear stress that causes 
barrier breakdown in vivo. Furthermore, the current microfluidic device exhibits a fixed 
bifurcation geometry, since the inlet is offset by 45 degrees, and thus cannot mimic the 
variability present in cerebral bifurcations. Therefore, future work is required to determine 
whether barrier function is generally reduced adjacent to bifurcations in the brain or 
additional factors known to exacerbate the effects of disturbed flow in systemic 
vasculature24 also exert the same effect on the blood-brain barrier. 
However, despite these differences with in vivo vasculature, a particular advantage of this 
in vitro model is the use of CFD and PIV to predict and validate the complex flow fields 
generated in the device. These methods are vital to assuring consistency between the 
varying channels, since the fabrication of the cell-seeded hydrogels results in small 
differences in geometries that affect the flow field.  
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5.2. Impact Of Pulsatile Flow On The BBB 
 
          The perfusion system developed here represents a robust, reproducible platform to 
interrogate the response of cerebral endothelial cells to complex, time-dependent flow 
fields within 3D protein-based hydrogel microenvironments. Computational fluid 
dynamics predict a spatial and temporal varying flow field within the channel during 
application of pulsatile flow, and microparticle image velocimetry validates the model by 
measuring flow separation at several points within the flow waveform. Both the velocity 
and wall shear stress profiles demonstrate that disturbed flow patterns exhibit periodic 
changes in the length of recirculating flow varying from x = 0-mm to approximately 
0.55-mm along the near wall of the channel. Endothelial cells within the region of 
separated flow exhibited altered morphology and tight junctions as well as increased 
permeability compared to cells in the fully developed flow region downstream of the 
bifurcation. Overall, these results establish this perfusion system as a means to apply 
time-dependent, reproducible flow fields to complex vascular geometries, in addition to 
providing preliminary insight into the effect of pulsatile, disturbed flow on the integrity 
of the blood-brain barrier, 
The perfusion system has sufficient flexibility to mimic a variety of flow 
waveforms. The waveform used in this study mimics aspects of cerebral blood flow 
including the systolic and diastolic phases in addition to the inflection points. However, 
the effect of channel wall compliance can also be assessed in future studies. Intracranial 
pulsations may play an active role in intracranial fluid dynamics and brain compliance117. 
3D vessel models combined with the pulsatile perfusion system can be used to investigate 
the impact of wall compliance on the flow velocity and shear stress profiles. Furthermore, 
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future studies can also use non-Newtonian fluids to better understand blood flow in 
complex arterial topologies. 
      Moreover, the perfusion system can be used to learn more about the 
mechanobiological response of endothelial cells to complex flow regimes. The results 
presented here indicate that pulsatile disturbed flow attenuates barrier function compared 
to fully developed pulsatile flow. 
5.3. Establishing A Mechanistic Link Between Disturbed Flow And Aneurysm 
Formation  
 
           RNA sequencing found differences in gene expression between the disturbed and 
fully developed regions with 645 downregulated and 1040 upregulated genes respectively 
in the disturbed compared to the fully developed region. Additionally, lumican which has 
been implicated in ECM organization and collagen fibrillogensesis111-113, was shown to be 
significantly upregulated in the fully developed region. Furthermore, the experiments 
conducted demonstrated that lumican is involved in collagen fibrillogenesis and mediating 
barrier integrity. The downregulation of the protein is associated with barrier breakdown. 
However, knocking down lumican has no significant effect on the activity of RhoA. 
Therefore, the breakdown of the barrier and the reduced expression of lumican are not 
correlated to increased RhoA activation, suggesting that other mechanisms are involved.  
5.4. Future Work 
 
              These results are the first to identify lumican as a potential mediator of cerebral 
aneurysm formation and are therefore a starting point for translational studies that 
interrogate the proteoglycan as both a therapeutic target and diagnostic candidate. Previous 
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work in abdominal aneurysms have investigated using lumican levels to diagnose patients 
at risk for developing such aneurysms. Our results suggest that future studies can 
interrogate whether lumican is also a marker for cerebral aneurysms. Moreover, these 
results indicate that lumican is an important mediator of extracellular matrix mechanics. 
This finding can form the basis of future biophysics studies to determine how 
proteoglycans modify the properties of viscoelastic substrates, and use this knowledge to 
advance tissue engineering and regenerative medicine applications in order to increase the 






















1. Cucullo L, Hossain M, Puvenna V, et al. The role of shear stress in Blood-Brain 
Barrier endothelial physiology. BMC Neurosci 2011; 12: 40. 2011/05/17. DOI: 
10.1186/1471-2202-12-40. 
 
2. Bell RD and Zlokovic BV. Neurovascular mechanisms and blood-brain barrier 
disorder in Alzheimer's disease. Acta Neuropathol 2009; 118: 103-113. 2009/03/26. DOI: 
10.1007/s00401-009-0522-3. 
 
3. Di Marco LY, Venneri A, Farkas E, et al. Vascular dysfunction in the 
pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms 
and ensuing vicious circles. Neurobiol Dis 2015; 82: 593-606. 2015/08/28. DOI: 
10.1016/j.nbd.2015.08.014. 
 
4. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's 
disease. Nat Rev Neurosci 2004; 5: 347-360. 2004/04/22. DOI: 10.1038/nrn1387. 
 
5. Obermeier B, Daneman R and Ransohoff RM. Development, maintenance and 
disruption of the blood-brain barrier. Nat Med 2013; 19: 1584-1596. 2013/12/07. DOI: 
10.1038/nm.3407. 
 
6. Barakat A and Lieu D. Differential responsiveness of vascular endothelial cells to 
different types of fluid mechanical shear stress. Cell Biochem Biophys 2003; 38: 323-343. 
2003/06/10. DOI: 10.1385/cbb:38:3:323. 
 
7. Jeong JW, Park OK, Park YK, et al. Changes of the carotid artery Doppler flow 
velocity pattern after sublingual nitroglycerin in patients with hypertension. Korean J 
Intern Med 1998; 13: 22-26. 1998/04/16. DOI: 10.3904/kjim.1998.13.1.22. 
 
8. Haines N, Wang S, Undar A, et al. Clinical outcomes of pulsatile and non-
pulsatile mode of perfusion. J Extra Corpor Technol 2009; 41: P26-29. 2009/04/14. 
 
9. Ku DN, Giddens DP, Zarins CK, et al. Pulsatile flow and atherosclerosis in the 
human carotid bifurcation. Positive correlation between plaque location and low 
oscillating shear stress. Arteriosclerosis 1985; 5: 293-302. 1985/05/01. DOI: 
10.1161/01.atv.5.3.293. 
 
10. Ornitz DM and Itoh N. The Fibroblast Growth Factor signaling pathway. Wiley 
Interdiscip Rev Dev Biol 2015; 4: 215-266. 2015/03/17. DOI: 10.1002/wdev.176. 
11. Chen F, Ohashi N, Li W, et al. Disruptions of occludin and claudin-5 in brain 
endothelial cells in vitro and in brains of mice with acute liver failure. Hepatology 2009; 





12. Cristante E, McArthur S, Mauro C, et al. Identification of an essential endogenous 
regulator of blood-brain barrier integrity, and its pathological and therapeutic 
implications. Proc Natl Acad Sci U S A 2013; 110: 832-841. 2013/01/02. DOI: 
10.1073/pnas.1209362110. 
 
13. van Nieuw Amerongen GP, van Delft S, Vermeer MA, et al. Activation of RhoA 
by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine 
kinases. Circ Res 2000; 87: 335-340. 2000/08/19. DOI: 10.1161/01.res.87.4.335. 
 
14. Iliff JJ, Wang M, Zeppenfeld DM, et al. Cerebral arterial pulsation drives 
paravascular CSF-interstitial fluid exchange in the murine brain. J Neurosci 2013; 33: 
18190-18199. 2013/11/15. DOI: 10.1523/JNEUROSCI.1592-13.2013. 
 
15. Partyka PP, Godsey GA, Galie JR, et al. Mechanical stress regulates transport in a 
compliant 3D model of the blood-brain barrier. Biomaterials 2017; 115: 30-39. 
2016/11/26. DOI: 10.1016/j.biomaterials.2016.11.012. 
 
16. Coloma M, Schaffer JD, Carare RO, et al. Pulsations with reflected boundary 
waves: a hydrodynamic reverse transport mechanism for perivascular drainage in the 
brain. J Math Biol 2016; 73: 469-490. 2016/01/06. DOI: 10.1007/s00285-015-0960-6. 
 
17. Weksler BB, Subileau EA, Perriere N, et al. Blood-brain barrier-specific 
properties of a human adult brain endothelial cell line. FASEB J 2005; 19: 1872-1874. 
2005/09/06. DOI: 10.1096/fj.04-3458fje. 
 
18. McLoughlin A, Rochfort KD, McDonnell CJ, et al. Staphylococcus aureus-
mediated blood-brain barrier injury: an in vitro human brain microvascular endothelial 
cell model. Cell Microbiol 2017; 19 2016/10/22. DOI: 10.1111/cmi.12664. 
 
19. Hersom M, Helms HC, Pretzer N, et al. Transferrin receptor expression and role 
in transendothelial transport of transferrin in cultured brain endothelial monolayers. Mol 
Cell Neurosci 2016; 76: 59-67. 2016/08/29. DOI: 10.1016/j.mcn.2016.08.009. 
 
20. Masuda H, Shozawa T, Hosoda S, et al. Cytoplasmic microfilaments in 
endothelial cells of flow loaded canine carotid arteries. Heart Vessels 1985; 1: 65-69. 
1985/05/01. 
 
21. Cornhill JF, Herderick EE and Stary HC. Topography of human aortic 
sudanophilic lesions. Monogr Atheroscler 1990; 15: 13-19. 1990/01/01. 
 
22. Wong AJ, Pollard TD and Herman IM. Actin filament stress fibers in vascular 
endothelial cells in vivo. Science 1983; 219: 867-869. 1983/02/18. 
23. Chappell DC, Varner SE, Nerem RM, et al. Oscillatory shear stress stimulates 





24. Chiu JJ, Wang DL, Chien S, et al. Effects of disturbed flow on endothelial cells. J 
Biomech Eng 1998; 120: 2-8. 1998/07/24. 
 
25. DePaola N, Gimbrone MA, Jr., Davies PF, et al. Vascular endothelium responds 
to fluid shear stress gradients. Arterioscler Thromb 1992; 12: 1254-1257. 1992/11/11. 
 
26. Lei M, Archie JP and Kleinstreuer C. Computational design of a bypass graft that 
minimizes wall shear stress gradients in the region of the distal anastomosis. J Vasc Surg 
1997; 25: 637-646. 1997/04/01. 
 
27. Tardy Y, Resnick N, Nagel T, et al. Shear stress gradients remodel endothelial 
monolayers in vitro via a cell proliferation-migration-loss cycle. Arterioscler Thromb 
Vasc Biol 1997; 17: 3102-3106. 1997/12/31 23:48. 
 
28. Davies PF, Shi C, Depaola N, et al. Hemodynamics and the focal origin of 
atherosclerosis: a spatial approach to endothelial structure, gene expression, and function. 
Ann N Y Acad Sci 2001; 947: 7-16; discussion 16-17. 2002/01/25. 
 
29. Roy B, Das T, Mishra D, et al. Oscillatory shear stress induced calcium flickers in 
osteoblast cells. Integr Biol (Camb) 2014; 6: 289-299. 2014/01/22. DOI: 
10.1039/c3ib40174j. 
 
30. Seiffert E, Dreier JP, Ivens S, et al. Lasting blood-brain barrier disruption induces 
epileptic focus in the rat somatosensory cortex. J Neurosci 2004; 24: 7829-7836. 
2004/09/10. DOI: 10.1523/JNEUROSCI.1751-04.2004. 
 
31. Robert J, Button EB, Yuen B, et al. Clearance of beta-amyloid is facilitated by 
apolipoprotein E and circulating high-density lipoproteins in bioengineered human 
vessels. Elife 2017; 6 2017/10/11. DOI: 10.7554/eLife.29595. 
 
32. Daneman R and Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol 
2015; 7: a020412. 2015/01/07. DOI: 10.1101/cshperspect.a020412. 
 
33. Abbott NJ, Khan EU, Rollinson CM, et al. Drug resistance in epilepsy: the role of 
the blood-brain barrier. Novartis Found Symp 2002; 243: 38-47; discussion 47-53, 180-
185. 2002/05/07. 
 
34. Abbott NJ, Ronnback L and Hansson E. Astrocyte-endothelial interactions at the 
blood-brain barrier. Nat Rev Neurosci 2006; 7: 41-53. 2005/12/24. DOI: 
10.1038/nrn1824. 
 
35. Jiang L, Li S, Zheng J, et al. Recent Progress in Microfluidic Models of the 





36. Shimizu F, Nishihara H and Kanda T. Blood-brain barrier dysfunction in 
immuno-mediated neurological diseases. Immunol Med 2018; 41: 120-128. 2019/04/03. 
DOI: 10.1080/25785826.2018.1531190. 
 
37. Sharma G, Sharma AR, Lee SS, et al. Advances in nanocarriers enabled brain 
targeted drug delivery across blood brain barrier. Int J Pharm 2019; 559: 360-372. 
2019/02/06. DOI: 10.1016/j.ijpharm.2019.01.056. 
 
38. Iadecola C. The Neurovascular Unit Coming of Age: A Journey through 
Neurovascular Coupling in Health and Disease. Neuron 2017; 96: 17-42. 2017/09/29. 
DOI: 10.1016/j.neuron.2017.07.030. 
 
39. Hallmann R, Horn N, Selg M, et al. Expression and function of laminins in the 
embryonic and mature vasculature. Physiol Rev 2005; 85: 979-1000. 2005/07/01. DOI: 
10.1152/physrev.00014.2004. 
 
40. Patel JP and Frey BN. Disruption in the Blood-Brain Barrier: The Missing Link 
between Brain and Body Inflammation in Bipolar Disorder? Neural Plast 2015; 2015: 
708306. 2015/06/16. DOI: 10.1155/2015/708306. 
 
41. Tsukita S, Furuse M and Itoh M. Multifunctional strands in tight junctions. Nat 
Rev Mol Cell Biol 2001; 2: 285-293. 2001/04/03. DOI: 10.1038/35067088. 
 
42. Luissint AC, Artus C, Glacial F, et al. Tight junctions at the blood brain barrier: 
physiological architecture and disease-associated dysregulation. Fluids Barriers CNS 
2012; 9: 23. 2012/11/13. DOI: 10.1186/2045-8118-9-23. 
 
43. Cereijido M, Valdes J, Shoshani L, et al. Role of tight junctions in establishing 
and maintaining cell polarity. Annu Rev Physiol 1998; 60: 161-177. 1998/04/29. DOI: 
10.1146/annurev.physiol.60.1.161. 
 
44. Vorbrodt AW and Dobrogowska DH. Molecular anatomy of intercellular 
junctions in brain endothelial and epithelial barriers: electron microscopist's view. Brain 
Res Brain Res Rev 2003; 42: 221-242. 2003/06/07. DOI: 10.1016/s0165-0173(03)00177-
2. 
 
45. Luissint AC, Federici C, Guillonneau F, et al. Guanine nucleotide-binding protein 
Galphai2: a new partner of claudin-5 that regulates tight junction integrity in human brain 
endothelial cells. J Cereb Blood Flow Metab 2012; 32: 860-873. 2012/02/16. DOI: 
10.1038/jcbfm.2011.202. 
 
46. Koutsiaris AG, Tachmitzi SV, Batis N, et al. Volume flow and wall shear stress 
quantification in the human conjunctival capillaries and post-capillary venules in vivo. 




47. Dewey CF, Jr., Bussolari SR, Gimbrone MA, Jr., et al. The dynamic response of 
vascular endothelial cells to fluid shear stress. J Biomech Eng 1981; 103: 177-185. 
1981/08/01. DOI: 10.1115/1.3138276. 
 
48. Colgan OC, Ferguson G, Collins NT, et al. Regulation of bovine brain 
microvascular endothelial tight junction assembly and barrier function by laminar shear 
stress. Am J Physiol Heart Circ Physiol 2007; 292: H3190-3197. 2007/02/20. DOI: 
10.1152/ajpheart.01177.2006. 
 
49. Siddharthan V, Kim YV, Liu S, et al. Human astrocytes/astrocyte-conditioned 
medium and shear stress enhance the barrier properties of human brain microvascular 
endothelial cells. Brain Res 2007; 1147: 39-50. 2007/03/21. DOI: 
10.1016/j.brainres.2007.02.029. 
 
50. Chiu J-J and Chien S. Effects of Disturbed Flow on Vascular Endothelium: 
Pathophysiological Basis and Clinical Perspectives. Physiological reviews 2011; 91: 
10.1152/physrev.00047.02009. DOI: 10.1152/physrev.00047.2009. 
 
51. Zhang JH, Badaut J, Tang J, et al. The vascular neural network--a new paradigm 
in stroke pathophysiology. Nat Rev Neurol 2012; 8: 711-716. 2012/10/17. DOI: 
10.1038/nrneurol.2012.210. 
 
52. Dashti R, Hernesniemi J, Niemela M, et al. Microneurosurgical management of 
middle cerebral artery bifurcation aneurysms. Surg Neurol 2007; 67: 441-456. 
2007/04/21. DOI: 10.1016/j.surneu.2006.11.056. 
 
53. Acharya NK, Goldwaser EL, Forsberg MM, et al. Sevoflurane and Isoflurane 
induce structural changes in brain vascular endothelial cells and increase blood-brain 
barrier permeability: Possible link to postoperative delirium and cognitive decline. Brain 
Res 2015; 1620: 29-41. 2015/05/12. DOI: 10.1016/j.brainres.2015.04.054. 
 
54. Zhang XJ, Li CH, Hao WL, et al. Enlarged Anterior Cerebral Artery Bifurcation 
Angles May Induce Abnormally Enhanced Hemodynamic Stresses to Initiate Aneurysms. 
World Neurosurg 2018; 120: e783-e791. 2018/09/04. DOI: 10.1016/j.wneu.2018.08.167. 
 
55. Hassan T, Timofeev EV, Saito T, et al. A proposed parent vessel geometry-based 
categorization of saccular intracranial aneurysms: computational flow dynamics analysis 
of the risk factors for lesion rupture. J Neurosurg 2005; 103: 662-680. 2005/11/04. DOI: 
10.3171/jns.2005.103.4.0662. 
 
56. Levitt MR, Mandrycky C, Abel A, et al. Genetic correlates of wall shear stress in 
a patient-specific 3D-printed cerebral aneurysm model. J Neurointerv Surg 2019; 11: 




57. Betzer O, Shilo M, Opochinsky R, et al. The effect of nanoparticle size on the 
ability to cross the blood-brain barrier: an in vivo study. Nanomedicine (Lond) 2017; 12: 
1533-1546. 2017/06/18. DOI: 10.2217/nnm-2017-0022. 
 
58. Fede A, Frascaroli D, Vento MG, et al. [Antibiotic prophylaxis of infectious 
complications of cervico-facial surgery]. Ann Ital Chir 1990; 61: 199-202. 1990/03/01. 
 
59. Gaston JD, Bischel LL, Fitzgerald LA, et al. Gene Expression Changes in Long-
Term In Vitro Human Blood-Brain Barrier Models and Their Dependence on a Transwell 
Scaffold Material. J Healthc Eng 2017; 2017: 5740975. 2018/01/11. DOI: 
10.1155/2017/5740975. 
 
60. Hatherell K, Couraud PO, Romero IA, et al. Development of a three-dimensional, 
all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation 
Transwell models. J Neurosci Methods 2011; 199: 223-229. 2011/05/26. DOI: 
10.1016/j.jneumeth.2011.05.012. 
 
61. Naik P and Cucullo L. In vitro blood-brain barrier models: current and 
perspective technologies. J Pharm Sci 2012; 101: 1337-1354. 2012/01/04. DOI: 
10.1002/jps.23022. 
 
62. Alcendor DJ, Block FE, 3rd, Cliffel DE, et al. Neurovascular unit on a chip: 
implications for translational applications. Stem Cell Res Ther 2013; 4 Suppl 1: S18. 
2014/02/26. DOI: 10.1186/scrt379. 
 
63. Wilhelm I, Fazakas C and Krizbai IA. In vitro models of the blood-brain barrier. 
Acta Neurobiol Exp (Wars) 2011; 71: 113-128. 2011/04/19. 
 
64. Grigoryan B, Paulsen SJ, Corbett DC, et al. Multivascular networks and 
functional intravascular topologies within biocompatible hydrogels. Science 2019; 364: 
458-464. DOI: 10.1126/science.aav9750. 
 
65. Griep LM, Wolbers F, de Wagenaar B, et al. BBB on chip: microfluidic platform 
to mechanically and biochemically modulate blood-brain barrier function. Biomed 
Microdevices 2013; 15: 145-150. 2012/09/08. DOI: 10.1007/s10544-012-9699-7. 
 
66. Brown JA, Pensabene V, Markov DA, et al. Recreating blood-brain barrier 
physiology and structure on chip: A novel neurovascular microfluidic bioreactor. 
Biomicrofluidics 2015; 9: 054124. 2015/11/18. DOI: 10.1063/1.4934713. 
 
67. Herland A, van der Meer AD, FitzGerald EA, et al. Distinct Contributions of 
Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain 





68. Linville RM, DeStefano JG, Sklar MB, et al. Human iPSC-derived blood-brain 
barrier microvessels: validation of barrier function and endothelial cell behavior. 
Biomaterials 2019; 190-191: 24-37. 2018/11/06. DOI: 
10.1016/j.biomaterials.2018.10.023. 
 
69. Cucullo L, McAllister MS, Kight K, et al. A new dynamic in vitro model for the 
multidimensional study of astrocyte-endothelial cell interactions at the blood-brain 
barrier. Brain Res 2002; 951: 243-254. 2002/09/25. DOI: 10.1016/s0006-8993(02)03167-
0. 
 
70. Bogorad MI and Searson PC. Real-time imaging and quantitative analysis of 
doxorubicin transport in a perfusable microvessel platform. Integr Biol (Camb) 2016; 8: 
976-984. 2016/08/16. DOI: 10.1039/c6ib00082g. 
 
71. Zheng Y, Chen J, Craven M, et al. In vitro microvessels for the study of 
angiogenesis and thrombosis. Proc Natl Acad Sci U S A 2012; 109: 9342-9347. 
2012/05/31. DOI: 10.1073/pnas.1201240109. 
 
72. Miller JS, Stevens KR, Yang MT, et al. Rapid casting of patterned vascular 
networks for perfusable engineered three-dimensional tissues. Nat Mater 2012; 11: 768-
774. 2012/07/04. DOI: 10.1038/nmat3357. 
 
73. Adriani G, Ma D, Pavesi A, et al. A 3D neurovascular microfluidic model 
consisting of neurons, astrocytes and cerebral endothelial cells as a blood-brain barrier. 
Lab Chip 2017; 17: 448-459. 2016/12/22. DOI: 10.1039/c6lc00638h. 
 
74. Henderson JT and Piquette-Miller M. Blood-brain barrier: an impediment to 
neuropharmaceuticals. Clin Pharmacol Ther 2015; 97: 308-313. 2015/02/12. DOI: 
10.1002/cpt.77. 
 
75. Lai CH and Kuo KH. The critical component to establish in vitro BBB model: 
Pericyte. Brain Res Brain Res Rev 2005; 50: 258-265. 2005/10/04. DOI: 
10.1016/j.brainresrev.2005.07.004. 
 
76. Bernas MJ, Cardoso FL, Daley SK, et al. Establishment of primary cultures of 
human brain microvascular endothelial cells to provide an in vitro cellular model of the 
blood-brain barrier. Nat Protoc 2010; 5: 1265-1272. 2010/07/03. DOI: 
10.1038/nprot.2010.76. 
 
77. Paul G, Ozen I, Christophersen NS, et al. The adult human brain harbors 
multipotent perivascular mesenchymal stem cells. PLoS One 2012; 7: e35577. 
2012/04/24. DOI: 10.1371/journal.pone.0035577. 
 
78. Thomsen LB, Burkhart A and Moos T. A Triple Culture Model of the Blood-
Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes. PLoS One 




79. Katyshev V and Dore-Duffy P. Pericyte coculture models to study astrocyte, 
pericyte, and endothelial cell interactions. Methods Mol Biol 2012; 814: 467-481. 
2011/12/07. DOI: 10.1007/978-1-61779-452-0_31. 
 
80. Wang Q, Rager JD, Weinstein K, et al. Evaluation of the MDR-MDCK cell line 
as a permeability screen for the blood-brain barrier. Int J Pharm 2005; 288: 349-359. 
2004/12/29. DOI: 10.1016/j.ijpharm.2004.10.007. 
 
81. Eigenmann DE, Xue G, Kim KS, et al. Comparative study of four immortalized 
human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and 
optimization of culture conditions, for an in vitro blood-brain barrier model for drug 
permeability studies. Fluids Barriers CNS 2013; 10: 33. 2013/11/23. DOI: 10.1186/2045-
8118-10-33. 
 
82. Lippmann ES, Al-Ahmad A, Azarin SM, et al. A retinoic acid-enhanced, 
multicellular human blood-brain barrier model derived from stem cell sources. Sci Rep 
2014; 4: 4160. 2014/02/25. DOI: 10.1038/srep04160. 
 
83. Lippmann ES, Azarin SM, Kay JE, et al. Derivation of blood-brain barrier 
endothelial cells from human pluripotent stem cells. Nat Biotechnol 2012; 30: 783-791. 
2012/06/26. DOI: 10.1038/nbt.2247. 
 
84. Clark PA, Al-Ahmad AJ, Qian T, et al. Analysis of Cancer-Targeting 
Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced 
Pluripotent Stem Cell Blood-Brain Barrier Model. Mol Pharm 2016; 13: 3341-3349. 
2016/07/17. DOI: 10.1021/acs.molpharmaceut.6b00441. 
 
85. Helms HC, Abbott NJ, Burek M, et al. In vitro models of the blood-brain barrier: 
An overview of commonly used brain endothelial cell culture models and guidelines for 
their use. J Cereb Blood Flow Metab 2016; 36: 862-890. 2016/02/13. DOI: 
10.1177/0271678X16630991. 
 
86. Stebbins MJ, Wilson HK, Canfield SG, et al. Differentiation and characterization 
of human pluripotent stem cell-derived brain microvascular endothelial cells. Methods 
2016; 101: 93-102. 2015/11/01. DOI: 10.1016/j.ymeth.2015.10.016. 
 
87. Canfield SG, Stebbins MJ, Morales BS, et al. An isogenic blood-brain barrier 
model comprising brain endothelial cells, astrocytes, and neurons derived from human 
induced pluripotent stem cells. J Neurochem 2017; 140: 874-888. 2016/12/10. DOI: 
10.1111/jnc.13923. 
 
88. Hollmann EK, Bailey AK, Potharazu AV, et al. Accelerated differentiation of 
human induced pluripotent stem cells to blood-brain barrier endothelial cells. Fluids 




89. Wang YI, Abaci HE and Shuler ML. Microfluidic blood-brain barrier model 
provides in vivo-like barrier properties for drug permeability screening. Biotechnol 
Bioeng 2017; 114: 184-194. 2016/07/12. DOI: 10.1002/bit.26045. 
 
90. Man S, Ubogu EE, Williams KA, et al. Human brain microvascular endothelial 
cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment 
and utilize chemokines for T cell migration. Clin Dev Immunol 2008; 2008: 384982. 
2008/03/06. DOI: 10.1155/2008/384982. 
 
91. Andrews AM, Lutton EM, Cannella LA, et al. Characterization of human fetal 
brain endothelial cells reveals barrier properties suitable for in vitro modeling of the BBB 
with syngenic co-cultures. J Cereb Blood Flow Metab 2018; 38: 888-903. 2017/05/24. 
DOI: 10.1177/0271678X17708690. 
 
92. Virgintino D, Errede M, Robertson D, et al. Immunolocalization of tight junction 
proteins in the adult and developing human brain. Histochem Cell Biol 2004; 122: 51-59. 
2004/06/29. DOI: 10.1007/s00418-004-0665-1. 
 
93. Anstrom JA, Thore CR, Moody DM, et al. Immunolocalization of tight junction 
proteins in blood vessels in human germinal matrix and cortex. Histochem Cell Biol 
2007; 127: 205-213. 2006/09/08. DOI: 10.1007/s00418-006-0232-z. 
 
94. Galie PA and Stegemann JP. Simultaneous application of interstitial flow and 
cyclic mechanical strain to a three-dimensional cell-seeded hydrogel. Tissue Eng Part C 
Methods 2011; 17: 527-536. 2010/12/23. DOI: 10.1089/ten.TEC.2010.0547. 
 
95. Placone AL, McGuiggan PM, Bergles DE, et al. Human astrocytes develop 
physiological morphology and remain quiescent in a novel 3D matrix. Biomaterials 2015; 
42: 134-143. 2014/12/30. DOI: 10.1016/j.biomaterials.2014.11.046. 
 
96. Adamson RH, Lenz JF and Curry FE. Quantitative laser scanning confocal 
microscopy on single capillaries: permeability measurement. Microcirculation 1994; 1: 
251-265. 1994/12/01. 
 
97. Harris GM, Raitman I and Schwarzbauer JE. Cell-derived decellularized 
extracellular matrices. Methods Cell Biol 2018; 143: 97-114. 2018/01/10. DOI: 
10.1016/bs.mcb.2017.08.007. 
 
98. Bouhrira N, DeOre BJ, Sazer DW, et al. Disturbed flow disrupts the blood-brain 
barrier in a 3D bifurcation model. Biofabrication 2020; 12: 025020. 2019/11/19. DOI: 
10.1088/1758-5090/ab5898. 
 
99. Epshtein M and Korin N. Mapping the Transport Kinetics of Molecules and 





100. Neame PJ, Kay CJ, McQuillan DJ, et al. Independent modulation of collagen 
fibrillogenesis by decorin and lumican. Cell Mol Life Sci 2000; 57: 859-863. 2000/07/13. 
DOI: 10.1007/s000180050048. 
 
101. Rada JA, Cornuet PK and Hassell JR. Regulation of corneal collagen 
fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp 
Eye Res 1993; 56: 635-648. 1993/06/01. DOI: 10.1006/exer.1993.1081. 
 
102. Krishnan A, Li X, Kao WY, et al. Lumican, an extracellular matrix proteoglycan, 
is a novel requisite for hepatic fibrosis. Lab Invest 2012; 92: 1712-1725. 2012/09/26. 
DOI: 10.1038/labinvest.2012.121. 
 
103. Bowers HC, Fiori ML, Khadela JB, et al. Cell-matrix tension contributes to 
hypoxia in astrocyte-seeded viscoelastic hydrogels composed of collagen and hyaluronan. 
Exp Cell Res 2019; 376: 49-57. 2019/01/19. DOI: 10.1016/j.yexcr.2019.01.012. 
 
104. Rossitti S and Stephensen H. Temporal heterogeneity of the blood flow velocity 
at the middle cerebral artery in the normal human characterized by fractal analysis. Acta 
Physiol Scand 1994; 151: 191-198. 1994/06/01. DOI: 10.1111/j.1748-
1716.1994.tb09737.x. 
 
105. Westin JE, Lindgren HS, Gardi J, et al. Endothelial proliferation and increased 
blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-
dihydroxyphenyl-L-alanine-induced dyskinesia. J Neurosci 2006; 26: 9448-9461. 
2006/09/15. DOI: 10.1523/JNEUROSCI.0944-06.2006. 
 
106. Tanweer O, Wilson TA, Metaxa E, et al. A comparative review of the 
hemodynamics and pathogenesis of cerebral and abdominal aortic aneurysms: lessons to 
learn from each other. J Cerebrovasc Endovasc Neurosurg 2014; 16: 335-349. 
2015/01/20. DOI: 10.7461/jcen.2014.16.4.335. 
 
107. Vanhoutte PM. Endothelium and control of vascular function. State of the Art 
lecture. Hypertension 1989; 13: 658-667. 1989/06/01. DOI: 10.1161/01.hyp.13.6.658. 
108. Minick CR, Stemerman MG and Insull W, Jr. Effect of regenerated endothelium 
on lipid accumulation in the arterial wall. Proc Natl Acad Sci U S A 1977; 74: 1724-1728. 
1977/04/01. DOI: 10.1073/pnas.74.4.1724. 
 
109. Alimperti S, Mirabella T, Bajaj V, et al. Three-dimensional biomimetic vascular 
model reveals a RhoA, Rac1, and N-cadherin balance in mural cell-endothelial cell-
regulated barrier function. Proc Natl Acad Sci U S A 2017; 114: 8758-8763. 2017/08/03. 
DOI: 10.1073/pnas.1618333114. 
 
110. Holdsworth DW, Norley CJ, Frayne R, et al. Characterization of common carotid 
artery blood-flow waveforms in normal human subjects. Physiol Meas 1999; 20: 219-




111. Chakravarti S, Stallings RL, SundarRaj N, et al. Primary structure of human 
lumican (keratan sulfate proteoglycan) and localization of the gene (LUM) to 
chromosome 12q21.3-q22. Genomics 1995; 27: 481-488. 1995/06/10. DOI: 
10.1006/geno.1995.1080. 
 
112. Kao WW, Funderburgh JL, Xia Y, et al. Focus on molecules: lumican. Exp Eye 
Res 2006; 82: 3-4. 2005/10/11. DOI: 10.1016/j.exer.2005.08.012. 
 
113. Ameye L and Young MF. Mice deficient in small leucine-rich proteoglycans: 
novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular 
dystrophy, and corneal diseases. Glycobiology 2002; 12: 107R-116R. 2002/09/06. DOI: 
10.1093/glycob/cwf065. 
 
114. Yang C-T, Li J-M, Chu W-K, et al. Downregulation of lumican accelerates lung 
cancer cell invasion through p120 catenin. Cell Death & Disease 2018; 9: 414. DOI: 
10.1038/s41419-017-0212-3. 
 
115. De Bock M, Van Haver V, Vandenbroucke RE, et al. Into rather unexplored 
terrain-transcellular transport across the blood-brain barrier. Glia 2016; 64: 1097-1123. 
2016/02/09. DOI: 10.1002/glia.22960. 
 
116. Knowland D, Arac A, Sekiguchi KJ, et al. Stepwise recruitment of transcellular 
and paracellular pathways underlies blood-brain barrier breakdown in stroke. Neuron 
2014; 82: 603-617. 2014/04/22. DOI: 10.1016/j.neuron.2014.03.003. 
 
117. O'Rourke MF and Hashimoto J. Mechanical factors in arterial aging: a clinical 














Characterization Of The Channel Geometry  
 








































Figure C1. Electrical connections and feedback, along with the flow circuit used to 
























Figure D1. Microparticle image velocimetry experiment. The tracer solution was 
prepared from Nile Red-labeled Polyethylene Microspheres (Peak excitation: 640nm; 
mean diameter 1.95um; Spherotech Inc.) The beads were illuminated and visualized with 




















Figure E1. Confirmation of tight junction formation and disruption. A-C) Composite 
images of occludin (red), DAPI (blue), and phalloidin (green) (i) and with occludin 
isolated (ii) of the endothelial cells along the near side wall in static conditions (A) and in 
perfused channels at the fully developed (B) and stagnation point of the disturbed region 
(C). D-F) Composite images of occludin (red), DAPI (blue), and phalloidin (green) (i) 
and with occludin isolated (ii) of the endothelial cells along the near side wall in static 
conditions (D) and in perfused channels at the fully developed (E) and stagnation point of 










Figure F1. A) Dextran transport across the axial direction, B)Dextran transport across 
the radial direction, C) Relative intensity along the axial distance and, D) Relative 








Final 3D Printed Components 
 
 
Figure G1. Device construction and assembly. A) CAD renderings (Solidworks) of the 
syringe components. B) Photographs of the printed components. C) CAD rendering of the 
linear actuator-syringe assembly. 
 





 Impact Of Disturbed Flow On Lumican Protein Expression  
 
 
Figure H1. Rheometer setup used for the study of the impact of disturbed flow on protein 
expression 
 
 
 
 
 
 
 
 
